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Summary  This  thesis  investigates  the  molecular  mechanisms  involved  in  T‐cell  receptor  (TCR)  signaling during  thymocyte  selection.  The  T‐cell  receptor  of  developing  T‐cells  interacts  with  antigen‐presenting  cells  (APCs)  that  display  peptide‐MHC  ligands  (p‐MHC)  of  different  nature  on  their surface. The TCR interacts with these ligands and translates the binding affinity for different p‐MHC (characterized by  the dissociation constant, KD)  into a quantitative readout,  thereby providing  the basis  for  downstream  signaling.  How  the  TCR  distinguishes  between  high  affinity  ligands  that induce apoptosis of individual thymocytes (negative selection) and low affinity ligands that induce differentiation  of  thymocytes  into  single‐positive  immature  T‐cells  (positive  selection)  has fascinated immunologists and biochemists for many years. This mechanism is critical to establish a self‐MHC restricted, self‐tolerant T‐cell repertoire (central tolerance).  The first part of this thesis investigates the molecular interaction between the TCR and the CD8 co‐receptor  in  thymic  selection.  By  tagging  both  molecules  with  variants  of  the  green  fluorescent protein (GFP) and assessing their molecular approximation in the immunological synapse by FRET microscopy (developed by P. Yachi and N. Gascoigne at the Scripps Institute, LaJolla, USA), we found that  negative‐selecting  p‐MHC  ligands  induced  strong  and  sustained  TCR/CD8  association.  In contrast, positive‐selecting ligands induce weak and delayed TCR/CD8 association in the synapse of T‐cell hybridomas with antigen‐presenting cells (APCs). We found that the TCR/CD8 interaction in response  to  positive‐  or  negative‐selecting  ligands was  reflected  in  the  phosphorylation  of  the ζ‐chain.  Therefore,  the  ability  of  the  TCR  to  tightly  associate  with  the  co‐receptor  is  the  critical parameter  that  determines  whether  a  p‐MHC  ligand  mediates  strong  intracellular  tyrosine phosphorylation  and  subsequently  induces  negative  selection  signaling.  The  α‐chain  connecting peptide motif (α‐CPM) is a region of 8 conserved amino acids in the membrane‐proximal part of the constant region of the TCR α‐chain. Mutating the α‐CPM did not affect ligand binding since α‐CPM mutant  TCRs  had  similar  p‐MHC  affinities  like wild‐type  TCRs.  However,  TCR/CD8  interaction  as measured  by  FRET  microscopy,  changed  substantially  in α‐CPM  mutant  TCRs.  In  response  to negative‐selecting ligands, TCR/CD8 association was reduced in α‐CPM mutant cells, which was also reflected in decreased ζ phosphorylation. Remarkably, in response to positive‐selecting ligands, α‐CPM  mutant  cells  displayed  no  detectable  TCR/CD8  interactions  and  failed  to  induce  ζ phosphorylation. Therefore,  the α‐CPM is responsible  for  the molecular approximation of  the CD8 co‐receptor to the TCR complex, allowing efficient signaling initiation. We hypothesize that the TCR and  the  co‐receptor may act  like a molecular  zipper. By binding  to  the  same p‐MHC molecule  the zippering mechanism allows the two molecules to become tightly associated via the α‐CPM towards 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1.1 T­cell development in the thymus T‐cells  develop  in  the  thymus  from  bone  marrow  progenitor  cells.  Within  the  thymus,  T‐cell precursors progress through a sequence of phenotypically distinct stages. Early CD4‐ CD8‐ double‐negative  (DN)  precursors  are  further  subdivided  based  on  their  CD44  (hyaluronic  acid  binding adhesion  molecule)  and  CD25  (the  α‐chain  of  the  IL‐2  receptor)  expression.  The  earliest  T‐cell precursors  in  the  thymus  comprise  the CD44+ CD25‐ DN1 subset. They advance  through  the  cKit+ (stem cell  factor  receptor) CD44+ CD25‐ DN2 stage  to become cKit‐ CD44‐ CD25+ DN3 cells. Genes encoding  β,  γ  and  δ  chains  of  the  TCR  rearrange  in  the  DN2  and  DN3  subsets  and  if  they  are productive express either the pre‐TCR (together with the pre‐TCR invariant α‐chain) or the γδ TCR on  the  surface.  For  pre‐TCR‐expressing  cells,  this  transition  is  called β‐selection.  Cells within  the DN3 population that have not yet succeeded in TCR gene rearrangement and surface expression do not  proliferate  further.  However,  TCR‐expressing  cells  downmodulate  CD25  and  advance  to  the CD44‐  CD25‐  DN4  stage.  Thymocytes  committed  to  the  αβ  lineage  become  CD4+  CD8+  double‐positive (DP)  in contrast  to γδ cells  that do not progress through the DP stage. Cells committed to the αβ  lineage are  silencing γ‐chain expression, deleting  the δ  locus and  start  to  rearrange  the α‐chain, eventually leading to expression of the αβ TCR on the cell surface. Some plasticity in lineage commitment remains  inherent  to a DN3 stage  thymocyte, since a TCR γδ+ cell can still give rise  to both αβ  and γδ  lineage. One hypothesis  suggests  that  rather  than  the  type of TCR,  the strength of TCR signaling determines the lineage outcome, with strong signaling favoring γδ and weak signaling 
αβ  lineage  development  (1).  Conversely,  another  theory  suggests  that  commitment  to  γδ  or  αβ lineages occurs before TCR expression at the DN2 stage and TCR signaling has rather a confirmatory role in commitment (2).  Developmental  stages  of  thymocytes  take  place  in  separated  locations  within  the  thymus. Progenitor  cells  from  the bone marrow enter  the  thymus  through high endothelial  venules  at  the cortico‐medullary  junction. First,  they migrate to the subcapsular region of  the cortex, where they undergo  vigorous  expansion,  which  is  driven  by  the  pre‐TCR.  As  maturation  proceeds  and  TCR rearrangement  is  completed,  DP  cells  migrate  deeper  into  the  cortex.  Interaction  with  cortical epithelial  cells  that  express  both MHC  class  I  and  class  II molecules,  is  the  foundation  of  positive selection  (chapter  1.2).  Immature  DP  thymocytes  then  migrate  towards  the  cortico‐medullary junction and into the medulla, where they interact with dendritic cells, macrophages and medullary epithelial  cells.  Compared  to  the  cortex,  there  are  substantially  less  cells  in  the  medulla.  Before maturation is completed, developing thymocytes are subjected to negative selection (chapter 1.2) to remove self‐reactive cells. 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The time between the entry of a T‐cell progenitor cell into the thymus and its export as immature T‐cell is estimated to take about 3 weeks in a mouse. Once maturation is completed, CD8+ or CD4+ SP cells leave the thymus either returning to the bloodstream directly via venules or via the lymphatic system.   
1.2 Positive and negative selection of thymocytes DP  thymocytes  undergo  one  of  the  following  cell  fates:  they  either  fail  to  recognize  peptide‐MHC ligands and die ‘by neglect’ or they are positively or negatively selected. Death by neglect comprises the vast majority of developing thymocytes (~90‐95%) and involves autoinduced cell death due to the αβ TCR’s failure to engage peptide‐MHC ligands, thereby not providing a survival signal to the cell.  Positive  selection and differentiation  into  SP T‐cells  is  based on  restriction  to  the own  set  of MHC molecules and combinatorial recognition of the presented peptide with moderate TCR binding affinity.  The  nature  of  the  selecting  peptide  has  been  controversial,  but  some  of  them  have  been identified  by  different  strategies.  In  several  TCR  transgenic  systems  it  turned  out  that  among putative  self‐peptides  (based  on  their  homology  to  an  original  positive  selecting  peptide)  only  a minority  of  candidates was  able  to  promote  selection,  suggesting  that  the number  of  functionally relevant  self‐peptide  ligands  is  low.  Therefore,  relatively  rare,  low‐affinity  self‐peptides  promote positive selection, giving rise to mature T‐cells with potentially high affinity for foreign peptides in the periphery (referred to as foreign, agonist or antigenic peptides). Ligand‐dependent signaling is a prerequisite  for  selection,  whereas  β‐selection  is  thought  to  result  from  ligand‐independent signaling. The role of the CD3 molecules, the scaffold proteins of TCR signaling, is difficult to study since  deletion  of  the  genes  encoding  for  either  CD3γ,  CD3ε  and  ζ  results  in  an  early  block  of thymocyte  development,  before  the  DP  stage.  Interestingly,  CD3δ  deficiency  does  not  impair  the generation  of  DP  cells  but  abrogated  positive  selection.  A  plausible  explanation  for  this  apparent contradiction comes  from a specific motif  in  the TCR α‐chain connecting peptide (α‐CPM; chapter 1.5) which is required for positive selection (3) and pMHC‐induced TCR/co‐receptor interaction (4), and which  is  important  for  retaining CD3δ  in  the TCR complex. This  suggests  that CD3δ  deficient thymocytes, even though they develop past the ligand‐independent β‐selection step, do not undergo positive  selection  because  the  trimeric  TCR‐pMHC‐co‐receptor  interaction  is  disrupted.  CD3δ  has also been implied in transmitting a conformational change of the TCR upon ligand binding, further supporting  its  role  in maintaining  the  integrity  of  the TCR/CD3  complex  at  developmental  stages where TCR‐mediated signaling is required. By providing a three‐dimensional microenvironment, cortical epithelial cells are quintessential  for productive  positive  selection.  Successful  epithelial  cell  differentiation  requires  thymocytes  and efficient thymocyte development requires epithelial cells. Recombination‐deficient mice (that have no  B‐  and  T‐cells)  are  disorganized  and  lack  the  normal  three‐dimensional  epithelial  network, 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emphasizing  this  ‘crosstalk’  situation.  By  the  use  of  two‐photon  laser  scanning  microscopy,  the vigorous movement of single thymocytes around their environment can be visualized. Thymocytes that  sample  signals  from  the  epithelial  cells  halt  their  migration  upon  encounter  of  a  positive selecting peptide and then adhere to epithelial cells for several hours. The principle of negative  selection  is  to  cause deletion of  thymocytes  that would  respond  to  ‘self’ ligands in the periphery. The elimination of self‐reactivity in the thymus is extremely sensitive and based  on  recognition  of  self‐ligands  predominantly  presented  by  medullary  epithelial  cells.  The transcription  factor  AIRE  induces  an  array  of  peripheral‐tissue  antigens  in  these  cells  and  its deletion results in multiorgan inflammatory infiltrates and generation of autoantibodies (5, 6).  Taken  together,  thymic  selection  establishes  a  diverse,  self‐MHC  restricted,  self‐tolerant  T‐cell repertoire (referred to as central tolerance). Recently the principle of thymic selection became more precisely defined (7). Several different MHC class  I‐restricted TCRs use the same apparent affinity threshold  of  TCR‐pMHC‐CD8  interaction  to  discriminate  between  positive  and  negative  selecting ligands.  Therefore,  for  class  I  restricted  T‐cells,  this  threshold  is  likely  to  be  universal  and consequently defines  the basis of  self  tolerance and T‐cell  specificity.  Inside  the cell,  the signaling machinery ensures that the threshold is precisely translated into diverging cellular responses (8).  
1.3 CD4/CD8 lineage decision During  thymic  selection,  the  CD4  and  CD8  co‐receptors  are  central  in  determining  whether  a developing  DP  thymocyte  becomes  a  CD4+  or  a  CD8+  single  positive  (SP)  T‐cell  (Figure  1).  DP thymocytes expressing MHC class II restricted TCRs differentiate into CD4+ SP T‐cells, whereas DP thymocytes expressing MHC class I restricted TCRs differentiate into CD8+ SP T‐cells. Therefore, the CD4/CD8‐lineage choice is determined by the MHC‐restriction specificity of the αβ TCR. Given that the  TCR’s  specificity  is  randomly  generated  by  somatic  recombination,  it’s  formally  possible  that non‐MHC  ligands may bind  to  the TCR. A possible explanation comes  from Lck,  a  critical  tyrosine kinase for the initiation of TCR signaling (chapter 1.6) that is associated with the co‐receptor.  Since there  is  little  ‘free’ Lck  in DP  thymocytes,  only  co‐engagement of pMHC with  the TCR and  the  co‐receptor results in successful signaling initiation. 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Figure 1. T-cell development in the thymus. CD4- CD8- double-negative (DN) cells differentiate into CD4+ CD8+ 
double-positive (DP) cells, which are the first cells to express a functional αβ TCR. DP thymocytes with potentially 
useful TCR specificities undergo positive selection and become intermediate CD4+ CD8low cells, which are still 




affinities are presumably similar). A higher percentage of CD4 co‐receptors are associated with Lck than  CD8  and  since  the  total  amount  of  Lck  in  a  thymocyte  is  limiting,  this may  contribute  to  a stronger overall signal. The duration‐of‐signal model provided the basis for the most recent model of  CD4/CD8  lineage  commitment,  called  the  kinetic  signaling model  (9).  Positively  selecting  TCR signals  induce  DP  thymocytes  to  terminate  cd8  gene  expression  and  to  convert  into  CD4+  CD8low intermediates,  in  which  the  lineage  choice  is  made.  Persistence  of  TCR  signaling  in  CD4+  CD8low intermediate  thymocytes  blocks  IL‐7 mediated  signaling  and  induces  differentiation  into  CD4+  SP cells. Cessation of TCR signaling allows IL‐7 mediated signaling leads to co‐receptor reversal in CD4+ CD8low intermediate thymocytes and differentiation into CD8+ SP cells.  
1.4 The T­cell receptor complex The  αβ  TCR  recognizes  antigen  by  a  specifically  binding  to  a  short  peptide  bound  to  an  MHC molecule  on  the  surface  of  an  APC  (10,  11).  Besides  critical  residues  on  the  peptide,  the  TCR recognizes a substantial portion of the MHC molecule, which is the basis of self‐MHC restriction. The 
αβ TCR complex consists of the rearranged α‐ and the β‐chain and 3 dimeric CD3 chains, δε, γε and 
ζζ. The transmembrane regions of the CD3 molecules contain acidic residues and the TCR α‐ and β‐chain  contain  basic  residues,  thereby  providing  electrostatic  attraction  among  the  different components  of  the  TCR/CD3  complex.  The  CD3  chains  contain  a  total  of  ten  immunoreceptor tyrosine‐based activation motifs  (ITAMs)  in  their cytoplasmic  tails, one  in each molecule of  the δε and  γε  heterodimers  and  three  in  each  ζ‐chain  of  the  homodimer.  These  motifs  are  important signaling modules and provide the scaffold for TCR signaling (Figure 2). 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Figure 2. Composition of the TCR/CD3 complex (adapted from (12)). Extracellular, transmembrane and intracellular 
regions are shown. The CD3δε heterodimer is located on the α-chain side of the TCR, whereas the CD3γε 
heterodimer is positioned next to the TCR β-chain. Acidic residues in the transmembrane regions of the CD3 
molecules are depticted in red and the basic TCR transmembrane residues are colored in blue. The two acidic-one 
basic electrostatic interactions are depicted in the red to blue ovals. The intracellular ITAMs are shown as grey ovals.   TCRs  bind  pMHC  via  their  complementarity‐determining  region  (CDR)  loops,  namely  germ  line encoded CDR1 (α/β), CDR2 (α/β) and (partially) somatically rearranged CDR3 (α/β) of the Vα and Vβ  chains,  respectively.  The  engaged TCR  lies diagonally  above  the pMHC  surface, which  is made from 2 α‐helices that define a groove where the peptide is attached to the MHC. The six CDR loops of the  TCR  contact  this  surface  to  varying  degrees.  Usually,  CDR1β  and  CDR2β  interact with  the α1 helix of MHC class I or the α helix of MHC class II, whereas CDR1α and CDR2α bind to the α2 helix of MHC class  I or  the β helix of MHC class  II. The  interactions of CDR3α and CDR3β usually  focus on amino acids of the peptide. The angle and pitch with which TCRs settle onto MHC varies because of differences in peptide and CDR3 sequences. Recent studies indicate that the TCR V regions have emerged through evolution to react with MHC, which prevents the majority of thymocytes to undergo negative selection or death by neglect (13). Thus, CDR1s and CDR2s of most Vα/Vβ  combinations  can produce  inherently MHC‐reactive TCRs and  CDR3s  sterically  interfere  differently  with  this  reactivity.  This  is  the  principle  to  produce  a repertoire of TCRs with a wide range of affinities for MHC.   
1.5 TCR co­receptor interactions The CD8 and CD4 co‐receptors participate in antigen recognition by binding to structurally similar 
α3 helices of MHC class I and class II molecules, respectively (14‐17). The co‐receptor binding sites are  separated  from  the MHC’s  peptide‐binding  groove  and  therefore  don’t  interfere with  antigen recognition.  Therefore,  CD8‐pMHC  interaction  is  independent  of  the  peptide  potency  (18).  By binding to the same pMHC molecule as the TCR (19), one of the co‐receptor’s functions is to stabilize this trimeric interaction (20‐22). In the absence of CD8 binding to pMHC, primary CD8 T‐cells fail to form conjugates with APCs, even  in  the presence of high concentrations of antigenic peptide (23). While  high‐affinity  TCR‐pMHC  interactions  (KD  <  6µM)  exhibit  a  certain  independency  of  CD8 coengagement,  low‐affinity  interactions  (KD  ≥  6µM)  require  CD8  to  enhance  sensitivity  (24). Thereby, the CD8αβ co‐receptor, but not the CD8αα co‐receptor significantly increases the affinity of  TCR‐pMHC  binding  (referred  to  as  apparent  affinity),  as  measured  by  binding  to  soluble monomeric pMHC (25). The same study suggests that CD8β not only facilitates TCR signal induction by  increasing  the  apparent  affinity  of  TCR‐pMHC  binding,  but  also  by  docking  TCR/CD3  to 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glycolipid‐enriched  microdomains  (GEMs).  Another  important  function  of  the  CD8  and  CD4  co‐receptors is their association with the Src tyrosine kinase Lck (26), which is critically involved in the initiation  of  TCR  signaling  and  thymocyte  development  (27‐29).  Lck  is  a  major  kinase  to phosphorylate  the  ITAMs  of  the  CD3  molecules  of  the  TCR/CD3  complex  (30).  The  tyrosine phosphorylation  pattern  of  an  agonist  ligand  can  be  converted  into  a  partial  agonist  pattern  by blocking  the  recruitment  of  CD4  to  the  TCR,  attributing  the  effect  to  the  amount  of  co‐receptor‐associated Lck (31).  An  important  role  of  the  molecular  interaction  between  CD8  and  the  TCR  was  assigned  to  a sequence  in  the  constant  region  of  the TCR α‐chain  termed α‐chain  connecting peptide motif  (α‐CPM) (3, 32). It was observed that α‐CPM deficient T‐cell hybridomas exhibit a substantial defect in engaging  CD8  for  pMHC  binding  that  could  not  be  attributed  to  a  TCR‐intrinsic  defect  in  pMHC binding (4). Mutations in this conserved motif of 8 amino acids (FETDxNLN) were initially described to promote unresponsiveness to TCR crosslinking or superantigens and later to promote defective positive  selection, whereas  negative  selection was  unaffected  (3,  33).  The  presence  of  the α‐CPM promotes positive selection by specifically activating the extracellular‐regulated signal kinase (ERK) in  a  weak  but  sustained  manner  (34).  Investigating  the  molecular  composition  of  the  TCR/CD3 complex revealed that α‐CPM negative thymocytes and T‐cells exhibit reduced association with the CD3δ subunit (3). Another study described that CD8αβ, but not CD8αα,  is associated with the TCR via CD3δ (35). Similar to α‐CPM negative thymocytes, CD3δ‐deficiency is also reflected in defective positive  selection,  underlining  the  functional  link  between  these  two molecules  since  both  fail  to cooperate with the co‐receptor. Time‐lapse movies of T‐cells hybridomas interacting with APCs showed that recruitment of the CD4 co‐receptor  to  the  immunological  synapse  (chapter  1.6.1)  was  almost  instantaneous,  with concentrations  of  CD4 detectable within  10  seconds  of  contact  (36).  Recruitment  of  CD4,  but  not CD3ζ was found when the T‐cell interacted with APCs that were not loaded with antigen, although CD4 recruitment to the immunological synapse in the absence of antigenic stimulation was slower than that seen when antigen was present. This shows that recognition of antigen increases the rate of  CD4  translocation  to  the  immunological  synapse.  CD4  recruitment  occured  only  if  mature dendritic cells or a subset of a B‐cell tumor was used as APCs, but not with immature dendritic cells nor with macrophages or MHC class II‐transfected fibroblasts. Similar experiments were performed with MHC class I‐restricted cells expressing CD3ζ‐CFP and CD8β‐YFP (37). Also in this case, the CD8 co‐receptor was recruited rapidly to the immunological synapse, although there was no difference between the presence or absence of antigen. In both CD4+ and CD8+ cells, co‐receptor concentration in  the contact area with  the APC was much more evident  than TCR concentration. The amount of CD8 recruited to the synapse correlates with the number of class I molecules on the surface of the APC, as shown with Tap‐deficient RMA‐S cells that only stabilize class I molecules on their surface 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upon addition of exogenous peptide. This clearly shows that CD8 recruitment is caused by the non‐cognate interaction between CD8 and MHC class I (37).   




Figure 3. Regulation of Lck (adapted from (41)). The dynamic equilibrium between inactive and active Lck  (left 
panel) is influenced by various factors such as the tyrosine phosphatase CD45 (not shown). Negative feedback by 
SHP-1 inhibits the enzyme (middle panel), whereas positive feedback by Erk overcomes SHP-1 inhibition and 
therefore activates the enzyme (right panel).  In  naïve  T‐cells,  CD3  ITAMs  are  to  some  degree  phosphorylated  (the  CD3ζ  p21  species  can  be detected in resting cells (42)) by activated Src‐family PTKs. The rate of ITAM dephosphorylation by phosphatases  such  as  SHP‐1  or  CD45  ensures  that  the  basal  phosphorylation  is  not  exceeded  in resting cells,  suggesting  that  this dynamic equilibrium does only  favor phosphorylation upon TCR triggering. Once both tyrosines within an ITAM of CD3ζ or ε are phosphorylated, the ζ‐chain associated protein of 70kDa (ZAP‐70), a PTK, can bind to the ITAM via its tandem Src‐homology 2 (SH2) domain. Since ZAP‐70 is of particular interest for the work presented in this thesis, it is discussed in greater detail in  chapter  1.7.  ZAP‐70  binding  to  phospho‐ITAMs  prolongs  the  transient  TCR‐pMHC  interaction, thereby  generating  a  more  sustained  intracellular  signal.  ZAP‐70  applies  its  kinase  activity  on multiple  downstream  signaling  and  adaptor  molecules.  An  important  target  of  ZAP‐70 mediated tyrosine  phosphorylation  is  the  linker  for  activation  of  T‐cells  (LAT),  a  GEM‐associated  adaptor protein.  Upon  phosphorylation  at  several  tyrosine  residues,  LAT  recruits  various  signaling  and other adaptor molecules  in order to diversify and regulate downstream signaling. Among the nine conserved tyrosines, the last four LAT tyrosines at position 132, 171, 191, and 226 (136, 175, 195 and 235 in mouse) are known to be important for LAT function. Besides ZAP‐70, Itk, and Lck have been  identified as  in vivo  LAT kinases. When phosphorylated,  these  four conserved LAT  tyrosines serve  as  docking  sites  for  SH2  domain‐containing  proteins,  including  phospholipase  C−gamma  1 (PLC‐γ1), Grb2, Gads and the p85 subunit of phosphoinositide 3‐kinase (PI3K) (43).  In  turn,  these molecules  recruit  SH3  domain  ligands  including  Src  homology  2  domain‐containing  leukocyte protein of 76kDa  (SLP‐76),  son of  sevenless  (SOS),  and  c‐Cbl.  Functional  studies have  shown  that 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Figure 4. Activatory steps in T-cell signaling (adapted from Cell Signaling Technologies). Some of the major effectors 
in TCR-, CD28 and LFA-1-mediated signaling are depicted schematically Proteins are color coded according to their 
function (table on the right). Some relevant transcription factors induced by these signaling pathways are shown in 
light blue although they are not covered by the manuscript.  
1.6.1 The immunological synapse Antigen recognition and signal initiation takes place at the interface between a T‐cell and an antigen presenting  cell  (APC),  which  is  called  the  immunological  synapse.  The  immunological  synapse consists of  a  central  zone,  the  central  supramolecular activation  cluster  (c‐SMAC), which  contains the  TCR  and  surface  accessory  molecules  such  as  the  co‐receptor,  CD2  and  CD28  (47,  48). Surrounding the central zone is another zone, the peripheral supramolecular activation cluster (p‐SMAC), which is enriched in adhesion molecules such as integrins and LFA‐1. Although the function of  the  immunological  synapse  has  not  been  entirely  elucidated,  it  is  the  area  of  adhesion  and sustained TCR‐pMHC interaction (37, 49). Microscopy provided insight into the first signaling steps of T‐cells. In a MHC class II restricted system, peripheral CD4 T‐cells were transduced with signaling constructs attached to fluorescent proteins. When these cells were stimulated by the presentation of agonist  peptide‐MHC  anchored  in  a  lipid  bilayer  on  a  slide,  spatio‐temporal  behaviour  of  these constructs  could  be  observed  by  total  internal  reflection  microscopy  (TIRFM)  (50).  TCR microclusters of about 11‐17 TCRs in size, were first generated in the c‐SMAC after very short time of contact (~5s) and then generated in the p‐SMAC that served to sustain the signal. Analysis of the 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signaling molecules ZAP‐70 and SLP‐76 revealed strong co‐localization with freshly generated TCR microclusters in the p‐SMAC. However, ZAP‐70 only partially moved towards the c‐SMAC together with  the  TCR  (and  the  fraction  that  did,  was  not  phosphorylated)  and  SLP‐76  disappeared completely  from central microclusters.  In a  further study, microcluster  formation was  found to be dependent  on  actin  cytoskeleton  remodeling,  probably  mediated  by  integrins  (51).  pMHC engagement forms F‐actin dependent microclusters that exlude the phosphatase CD45 and are the site of signal initiation. This may per se allow increased phosphorylation by tyrosine kinases in the cluster.  Additionally,  Lck  diffuses  into  the  clusters  from  surrounding  CD45‐rich  domains  (52). Migration  of  the microclusters  to  the  c‐SMAC  intermixes  CD45  again  and  signaling  stops.  The  c‐SMAC  is not  involved  in sustained Ca2+  signaling. Moreover, LBPA (a  lipid  that  is generated at  the site of multivesicular body formation and targets membrane proteins for degradation) accumulates in  the  c‐SMAC,  sorting  ubiquinated  TCR  for  degradation,  suggesting  that  the  c‐SMAC  is predominantly a site of signal termination and endocytosis of the TCR.  




1.6.3 Systematic signaling regulation The  stochastic  expression  of  signaling  molecules  provides  another  approach  to  explain  the variability (and with a closer look also the robustness) of cellular responses. For example, variable T‐cell responses to antigenic stimulation within a clonal population are necessary to allow for  the development of both effector and memory T‐cell  subsets  from  that population.  In a population of uniform,  agonist‐stimulated T‐cells,  the  Lck‐associated CD8  co‐receptor was  identified  as  positive analog regulator (CD8 expression correlates with the EC50 of activated cells as measured by ppERK) (53).  In  contrast,  SHP‐1  functions  as  negative  switch‐like  regulator  (SHP‐1  expression  negatively correlates with the strength of activation but the EC50 remains constant). Although this theoretically leads  to substantial variability  in  the responsiveness of a  single T‐cell  in a clonal population of T‐cells (based solely on the stochastic expression of signaling molecules), most antigen responses are highly  uniform.  To  ensure  this  robustness,  expression  levels  of  CD8  and  SHP‐1  appear  to  be  co‐regulated,  thereby  reducing  the  response  variation  (53).  In  the  bigger  context  of  an  immune response,  co‐regulation  decreases  the  number  of  hyperresponsive  cells  and  potentially  limits  the risk of self‐responsiveness of T‐cells.  
1.6.4 Ras/MAPK signaling Ras is a member of the large superfamily of small GTPases. Signal‐induced conversion of the inactive (GDP‐bound)  form  to  the  active  (GTP‐bound)  form  allows  downstream  signaling  elements  to  be engaged. The GDP to GTP exchange is mediated by guanine nucleotide‐exchange factors (GEFs). Due to  its GTPase activity, Ras  is a  self‐limiting,  rather poor enzyme. However,  the catalytic activity of Ras can be substantially improved by GEFs.  In  T‐cell  signaling,  N‐Ras  is  of  particular  importance.  Lymphoid  malignancies  linked  to  Ras mutations  are  almost  always  in  the  nras  gene  (54).  N‐Ras  deficient  mice  exhibit  defective  T‐cell function and are extremely sensitive to viral infections. Ras is required for thymocyte development, T‐cell  proliferation  and  IL‐2  production  (55).  Positive  selection  is  severely  affected  in  mice expressing a dominant negative form of Ras (56). In contrast, negative selection remains intact.  Ras proteins are associated to the plasma membrane but do not themselves have signal sequences or  hydrophobic  membrane‐spanning  domains.  Rather  they  are  modified  posttranscriptionally (including  prenylation,  palmitoylation  and  carboxyl‐methylation)  and  targeted  to  cellular membranes, which is believed to be required for biological activity. As for example, N‐Ras and H‐Ras undergo a palmitoylation/depalmitoylation cycle, which regulates their trafficking from the plasma 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membrane to the Golgi and back again (57). This bidirectional traffic may have a regulatory role in signaling.  The  best  characterized  Ras‐regulated  signaling  pathway  is  the  mitogen‐activated  protein  kinase (MAPK)  pathway  that  proceeds  through  the  MAP  kinases  Erk1  and  Erk2  (extracellular  signal‐regulated kinases). The adapter protein Grb2 connects TCR signals to the Ras pathway, since Grb2 is constitutively associated with SOS (son of sevenless) through its SH3 domain. SOS is a GEF for Ras proteins.  Therefore,  TCR  engagement  leads  to  the  recruitment  of  SOS  to  the  plasma  membrane, where  it encounters Ras. Once Ras  is activated,  it  recruits Raf‐1, a serine/threonine kinase whose complex  regulation  is  poorly  understood.  Raf‐1  phosphorylates  and  activates  MEK  (MAPK/Erk kinase), a dual specificity tyrosine/threonine kinase that in turn phosphorylates and activates Erk1 and Erk2. Erk proteins are serine/threonine kinases that have numerous targets, including cytosolic proteins. However, phospho‐Erk also forms dimers that can be transported into the nucleus in order to activate several transcription factors.  The  GEF  Ras  guanine  nucleotide‐realeasing  protein  1  (RasGRP‐1)  disrupts  thymic  selection indicating  that  Ras/MAPK‐mediated  signaling  downstream  of  the  TCR  is  essential  for  thymocyte development and further experiments confirmed that RasGRP‐1 is required for ideal TCR mediated Ras‐Erk activation (58). In T‐cells, RasGRP1 can translocate to the Golgi, leading to Ras activation in this organelle. Along the same lines, there is no Ras activity in PLC‐γ1 deficient T‐cells (which by its enzymatic  activity  produces  the  secondary  messenger  DAG  that  directly  binds  to  RasGRP‐1  and activates it). Nevertheless, Ras can be activated at the plasma membrane by signaling via Grb2/SOS in  response  to  strong,  but  not  to weak  stimuli  (59).  In  accordance with  this,  thymocyte  leads  to compartmentalization  of  Ras/MAP  kinase  signaling  (8).  In  response  to  high‐affinity,  negative‐selecting  pMHC  ligands,  RasGRP1,  Ras  and Raf‐1  are  recruited  to  the  plasma membrane whereas with  low‐affinity,  positive‐selecting  ligands  these  molecules  are  targeted  to  the  Golgi. Phosphorylated Erk is also targeted to the membrane in response to strong stimuli in contrast to Jun amino terminal kinase (Jnk), which remains distributed throughout the cell independent of the TCR input. Therefore, positive and negative selection are characterized by the cellular localization of the MAPK signaling molecules.   
1.6.5 Negative feedback in TCR signaling Besides  the  activating  mechanisms  there  are  several  inhibitory  and  negatively  regulating mechanisms  that  control  the outcome of TCR  induced signaling. Negative  feedback can  further be distinguished  by  their  mechanism  and  kinetics  of  induction.  Regulatory  mechanisms  that  are activated  by  inhibitory  membrane‐bound  receptors  include  CD28,  CD5,  cytotoxic  T‐lymphocyte antigen 4 (CTLA‐4), programmed cell death 1 (PD‐1) and those that control degradation of signaling components,  mainly  by  ubiquitylation.  Inhibitory  receptors  like  CD5,  PD‐1  and  CTLA‐4  are 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recruiting  protein  tyrosine  phosphatases  to  the membrane,  thereby  promoting  negative  feedback lasting  for  several  hours  after  TCR  stimulation.  They  modulate  TCR  signaling  in  effector  and memory T‐cells, as well as their differentiation. CTLA‐4 targets downstream signaling molecules of phosphatidylinositol  3‐kinase  (PI3K)  by  activating  the  serine/threonine  phosphatase  PP2A.  In contrast,  PD‐1  prevents  the  intracellular  accumulation  of  3‐phosphorylated  phosphatidylinositol lipids (by antagonizing PI3K directly), which are important second‐messenger molecules. However, both inhibitory pathways converge at the serine/threonine kinase Akt (also known as PKB) (60).  More proximal negative feedback mechanisms are rapidly activated simultaneously to the activation of  the  TCR  signalosome.  These  mechanisms  act  mainly  in  thymocytes  and  naïve  T‐cells  and  are induced by  the TCR  itself. Mice deficient  in SHP‐1  show enhanced positive and negative  selection and  T‐cell  activation.  Eventually,  these  mice  develop  autoimmunity.  Remarkably,  low‐affinity antagonist  pMHC  ligands  (which  do  not  activate  mature  T‐cells),  promote  SHP‐1  membrane recruitment  and  activation  whereas  high‐affinity  agonist  ligands  elicit  delayed  and  lower  SHP‐1 recruitment  (40,  61).  Consequently,  lowering  SHP‐1  activity  converts  antagonists  into  partial agonists  that  could  induce  calcium  signaling.  SHP‐1  binds  via  its  two  SH2‐domains  to immunoreceptor  tyrosine‐based  inhibitory  motifs  (ITIMs),  thereby  evolving  its  phosphatase activity.  Besides  binding  to  the  ITIMs  in  the  cytoplasmic  tails  of  inhibitory  receptors,  there  is evidence  that  SHP‐1,  upon  TCR‐antagonist  binding,  associates with  Lck,  becomes  phosphorylated and  in  turn downregulates Lck kinase activity (40, 61). Other  tyrosine phosphatases  like PTPN22, SHP‐2  or  DUSP‐5/6  strongly  enhance  TCR  sensitivity  when  they  are  collectively  silenced  by expression  of  the  micro‐RNA miR‐181a  (61).  However,  it’s  not  entirely  understood  whether  the miR‐181a  controlled  phosphatases  are  activated  as  negative  feedback  loop  following  TCR engagement or whether they act constitutively. TCR mediated antigen recognition is more sensitive in thymocytes. This allows positive selection by accumulation of low‐affinity TCR‐pMHC interactions that would not  lead  to stimulation of a peripheral T‐cell. Along  these  lines, shp­1 mRNA  levels are lower in DP thymocytes than in mature T‐cells and miR‐181a is highly expressed in DP thymocytes and  decreased  in  positively  selected  SP  thymocytes.  This  regulatory mechanism may  provide  the basis to explain the different TCR signaling sensitivity according to the developmental stage. Another negative feedback mechanism involves the cytoplasmic adaptor proteins DOK1 and DOK2 (downstream of kinase 1). These adaptors become tyrosine phosphorylated and interact with LAT as  a  multi‐protein  complex,  which  also  involves  SHIP‐1,  an  inositol  phosphatase.  The  protein complex  interferes  with  the  generation  of  secondary  signaling  messengers  and  the  membrane recruitment  of Akt.  Since  these  effects  correlate with  enhanced ZAP‐70  and LAT phosphorylation and ERK activation, this pathway represents another feedback loop that is acting on TCR‐proximal signaling  components. DOK1/2 negative mice  exhibit  increased TCR‐induced  cytokine  production and  proliferation,  show  increased  T‐cell  mediated  antibody  responses  and  develop  a  lupus‐like disease. 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How is a specific signal generated following the engagement of a TCR? The TCR‐pMHC interaction is characterized by the half‐life of binding, which is the average residual time of a pMHC ligand on the TCR. Once the ‘binding input’ is translated across the plasma membrane, tyrosine phosphorylations of the CD3 ITAMs provide the scaffold for the activation of intracellular signaling pathways (which in the case of the TCR can be fundamentally different, giving rise to proliferation/differentiation of a thymocyte  or  a  T‐cell  but  can  also  induce  their  apoptosis).  The  effectors  of  these  cascades  are kinases  and  phosphatases  (as  far  as  our  current  understanding  of  signaling  goes,  transfer  or withdrawal  of  phosphate  groups  to  tyrosine,  serine  or  threonine  residues  are  the  predominant means  to  regulate  signal  propagation).  Feedback  loops  (positive  and negative) modify  the  rate  of particular effector‐catalyzed reactions, thereby establishing new steady states. This can be achieved in several ways: targeting of proteins  into multi‐protein complexes or  into specific  locations (such as membrane GEMs) provides the basis of functional cooperativity. Cooperativity converts a graded response  into  a  switch‐like  response  (eg.  if  a  substrate  that  is  activated  by  an  enzyme  induces further increase of the enzyme). Biophysically, the response curve of a graded reaction is linear for low substrate concentrations and plateaus with  increasing substrate concentrations, being  limited by the maximal catalytic rate of a particular enzyme. In contrast, the response curve of a switch‐like reaction  has  a  sigmoid  shape  and  a  threshold  can  be  defined  (such  as  the  half‐maximal  catalytic rate).  The  degree  of  cooperativity  determines  how  sharp  the  threshold  is,  with  a  high  degree  of cooperativity  enhancing  the  switch‐like  character  of  a  response.  This  principle  ensures  the bivalency  of  an  enzymatic  response  and  ‘prevents’  intermediate  responses.  Mechanistically  this means  that subtle changes  in  the TCR‐pMHC half‐live are  translated  into switch‐like responses by the TCR‐proximal phosphorylation and dephosphorylation events,  thereby establishing a signaling threshold of activation.  
1.6.6 How TCR signaling distinguishes ligands ‘Steady state’ signaling in thymocytes and T‐cells  is controlled by positive and negative regulatory mechanisms that can be shifted by TCR‐pMHC engagement. High‐affinity TCR‐pMHC interactions, as characterized  by  an  extended  half‐life  of  TCR‐pMHC  binding,  strongly  activate  the  receptor‐proximal  kinases.  At  the  same  time,  phosphatases  that  downmodulate  the  kinase  activity  are induced, which  results  in  an overall  strong but  transient  tyrosione phosphorylation  cascade  (34). Negative  selection  is  characterized  by  relatively  coreceptor‐independent  extensive  CD3  ITAM phosphorylation and hence full LAT phosphorylation. This leads to recruitment of Grb2/SOS1, and transient activation of Ras and ERK at the plasma membrane. One prerequisite of negative selection is the switch‐like activation of Erk in the periphery in response to negative‐selecting ligands (8). In contrast, the integration of many signals of low apparent affinity leads to moderate but sustained kinase  activity  that  partially  overcomes  negative  regulation  (62).  Positive  selection  involves 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coreceptor‐dependent  signal  transmission  via  the  TCR’s  α‐CPM/CD3δ  and  leads  to  intermediate CD3 ITAM phosphorylation  (4).  Partial  LAT  phosphorylation  recruits  PLCγ‐1  and  Gads/Slp76/Itk, resulting  in  activation  of  PLCγ‐1  and production  of  diacylglycerol  (DAG)  and  calcium  signals.  The Ras  activator  RasGRP‐1  is  activated  by  DAG  binding  and  stimulates  sustained,  low‐level  ERK activation while moderate calcium signaling may be sufficient to induce gene transcription. Taken  together, TCR‐mediated signaling distinguishes negative‐  from positive‐selecting  ligands by inducing  positive  and  negative  effectors  with  different  kinetics  and  as  well  by  the  separation  of signaling components to either intracellular organelles or maintaining them in the periphery.  
1.7 A closer look at ZAP­70 
1.7.1 ZAP­70 discovery and relevance ZAP‐70  was  first  described  as  protein  tyrosine  kinase  (PTK)  that  is  associated  with  CD3z  and undergoes  tyrosine  phosphorylation  following TCR  engagement  (63).  ZAP‐70  deficient mice  have neither  CD4+  nor  CD8+  single‐positive  (SP)  T‐cells  (64).  Due  to  this  defect  in  positive  selection, thymocytes  are  arrested  in  their  double‐positive  (DP)  state  of  development. Negative  selection  is also impaired since these cells are unresponsive to pMHC ligands. Human ZAP‐70 reconstitutes both CD4+  and  CD8+  SP  populations,  underlining  the  central  role  of  this  tyrosine  kinase  in  T‐cell development.  
1.7.2 ZAP­70 binding to TCR ITAMs and activation In  cell‐free  assays,  fully  phosphorylated  dimeric  CD3ζ  is  sufficient  to  promote  ZAP‐70 autophosphorylation  and  catalysis  of  a  substrate  (65).  In  contrast,  monomeric  CD3ζ  does  not activate ZAP‐70,  independent of  its phosphorylation state. Murine  thymocytes exhibit  constitutive association of ZAP‐70 with partially phosphorylated (dimeric) CD3ζ, yet ZAP‐70 is not activated (66, 67).  The  discrepancy  between  these  in  vitro  and  in  vivo  findings  may  originate  from dephosphorylation mechanisms of CD3 ITAMs, which do not occur in the described cell‐free assay. This  regulation  prevents  full  CD3ζ  phosphorylation  in  resting  thymocytes  and  therefore  doesn’t activate  ZAP‐70.  Indeed,  the  tyrosine  phosphatase  SHP‐1  binds  to  ZAP‐70,  resulting  in  increased SHP‐1  phosphatase  activity  and  decreased  ZAP‐70  kinase  activity  (68,  69).  Thus,  SHP‐1  is  as negative regulator of ZAP‐70 and therefore TCR‐mediated signaling.  ZAP‐70 binds to tyrosine‐phosphorylated ITAMs of CD3ζ and CD3ε. The biophysical parameters for ZAP‐70 binding to these TCR subunits were determined by binding assays. The isolated N‐terminal SH2‐domain  of  ZAP‐70  binds  with  100‐fold  reduced  affinity  to  the  phosphorylated  cytoplasmic portion of CD3ζ  compared  to  the complete  tandem SH2‐domain  (70). No binding was observed  if
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the isolated C‐terminal SH2‐domain was used, which indicates positive binding cooperativity of the tandem SH2‐domains and  thereby ensures high affinity  for  the doubly phosphorylated  ITAM. The binding affinity of the ZAP‐70 tandem SH2‐domain to peptides containing individual CD3ζ  ITAMs as well as the CD3ε ITAM was measured and the hierarchy described as ITAM(ζ1) ≥ ITAM(ζ2) > ITAM (CD3ε)  ≥  ITAM  (ζ3)  (index  numbers  denote  the  N‐  to  C‐terminal  direction  of  CD3ζ  ITAMs)  (71). Affinity differences of as much as 30‐fold between the individual phospho‐ITAMs suggests that ZAP‐70  binds  to  ITAMs  sequentially,  provided  that  they  are  phosphorylated.  Indeed,  CD3ζ  ITAM phosphorylation  is  sequential  and  appears  to  be  ordered  (72).  A  basally  phosphorylated  form  of CD3ζ can be detected in resting cells (p21 form), whereas fully phosphorylated CD3ζ (p23 form) is induced  only  upon  stimulation  with  agonist  pMHC  ligands  presented  by  APCs  and  involves phosphorylation  of  all  6  tyrosines  within  the  3  CD3ζ  ITAMs.  Antagonist  pMHC  ligands  promote intermediate  CD3ζ  phosphorylation,  which  does  not  detectably  activate  ZAP‐70.  In  mice  with transgenic TCRs  either  restricted  for MHC  class  I  or  class  II,  the percentage of  positively  selected CD8+ or CD4+ SP cells, respectively, decreases when going from 3 intact CD3ζ ITAMs (wildtype) to 1 ITAM and to no ITAMs (73). This change of CD3ζ  ITAM multiplicity alters  the efficiency of  thymic selection  since ZAP‐70 binding  is  reduced  and downstream  signaling diminished. Along  the  same lines, T‐cell  clones  stimulated with altered peptide  ligands  (APLs)  induce only partial CD3ζ  ITAM phosphorylation,  which  greatly  reduces  ZAP‐70  activation  and  PLC‐γ1  mediated  phospholipid hydrolysis (74).  Besides Src family kinases such as Lck, ZAP‐70 itself is also involved in CD3 ITAM phosphorylation (75).  In  DP  thymocytes  with  limiting  coreceptor‐associated  Lck,  ZAP‐70  is  required  for  ITAM phosphorylation independent of its kinase activity (76). Rather than just protecting the ITAMs from dephosphorylation,  ZAP‐70  promotes  ITAM  phosphorylation  by  recruiting  Lck  via  SH2‐domain mediated interactions. Upon positive selection, the requirement for ZAP‐70 decreases as the amount of  Lck  available  to  the  TCR  quantitatively  increases.  In  accordance  with  this,  mice  with  a spontaneous mutation in the ZAP‐70 kinase domain failed to fully phosphorylate ζ, similar to ZAP‐70‐/‐ mice  (77),  further  supporting  the  idea  that  TCR‐associated  ZAP‐70  functions  as  adaptor  for coreceptor‐associated Lck in DP thymocytes.  
1.7.3 ZAP­70 mutational analysis Substitution of  tyrosine 319 with structurally similar phenylalanine (Y319F)  in  the  interdomain B leads to dominant negative ZAP‐70 behavior (78). Y319F prevents phosphorylation of further ZAP‐70 regulatory residues such as Y493, therefore inhibits the kinase activity and antigen‐induced IL‐2 expression. Evidence is provided that Y319 is a binding site for Lck (SH2‐domain mediated binding), which  in  turn  positively  regulates  ZAP‐70  (79).  Therefore,  a  ZAP‐70 mutant  carrying  the  optimal 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binding  site  for  the  SH2‐domain  of  Lck  (Y319EEI  instead  of  wildtype  Y319SDP)  displays  a  gain‐of‐function phenotype, exhibited by increased tyrosine phosphorylation and catalytic activity. Tyrosine phosphorylation at residue 493 in the kinase domain of ZAP‐70 is another positive regulatory step (80, 81). Substitution of Y493 with phenylalanine (Y493F) prevents ZAP‐70 activation even if Y493F is co‐expressed with constitutively active Lck. Another study suggests that Y315 and Y319 are not substrate recruiting residues in the first place. Rather, they function as autoinhibitory switch, thereby regulating ZAP‐70’s kinase activity (82). By phosphorylating  Y319  (and  possibly  Y315),  Lck  or  other  kinases  activate  ZAP‐70,  similar  to  the juxtamembrane  region  of  several  RTKs.  These  findings  were  supported  by  the  crystallographic structure of ZAP‐70 where phosphorylation at Y319 in the interdomain B promotes the separation between  the  tandem‐SH2  domain  and  the  kinase  domain  by  electrostatic  repulsion,  which  is necessary to activate the kinase (83). In contrast to the Y319F mutant, the Y315/319A mutant leads to  Y493  phosphorylation,  probably  via  an  intermolecular  trans‐phosphorylation  mechanism, arguing  for  an  open  conformation  of  the  Y315/319A  mutant  and  therefore  a  release  from autoinhibition, similar to the tyrosine‐phosphorylated wildtype ZAP‐70 (82). Along the same lines, Lck is not very efficient in phosphorylating Y493 in a kinase‐inactive ZAP‐70 mutant (K369A), even when Y319 was phosphorylated and available  for Lck‐binding. This suggests that phosphorylation of interdomain B Y315 and Y319 is the only phosphorylation step depending on kinases other than ZAP‐70 itself. However, these findings were contradictory to the observation that the K369A kinase‐inactive mutant was  hyperphosphorylated  at  both Y319  and Y493  in  Cos  or  293  cells.  Therefore, although not very efficient, Lck participates in phosphorylating Y493 (79). Hypothetically, Lck may be  responsible  for  the  initial  but  rather  inefficient  phosphorylation  of  Y493  on  several  ZAP‐70 molecules that trans‐autophosphorylate other ZAP‐70 molecules with which they are dimerized by paired ITAMs of the CD3 subunits.  
1.7.4 ZAP­70 structure Only recently the structure of full‐length, inactive ZAP‐70 has been resolved (83). In this model, the hinge  region of  the  kinase domain  forms  a network of  hydrogen bonds between  the  tandem‐SH2 domain and the kinase domain. The hydrogen bonds are broken in the active conformation allowing more  flexibility,  which  is  required  for  catalysis  (therefore,  inactive  ZAP‐70  is  considered ‘autoinhibited’).  Upon  SH2‐mediated,  specific  binding  to  doubly  phosphorylated  ITAMs,  the  side chain of Trp133 is moved away from Tyr315 and Tyr319, thereby disrupting the aromatic‐aromatic interaction,  which  is  normally  stabilizing  the  linker‐kinase  interface  (=interdomain  B).  This facilitates the access to phosphorylation sites Tyr315 and Tyr319 by Lck or potentially other PTKs (Figure 5). Therefore autoinhibition  is  released upon phosphorylation of  these  tyrosines residues. 




Figure 5. ZAP-70 ITAM binding (adapted from (83)). The conformational change of ZAP-70 is shown upon binding 
to a doubly phosphorylated ITAM peptide. Phosho-ITAM-bound ZAP-70 is susceptible to further phosphorylation 
steps at Y315/Y319 in the interdomain B and Y492/Y493 in the activation loop of the kinase domain. N-SH2: N-
terminal SH2-domain, C-SH2: C-terminal SH2-domain, N-lobe and C-lobe: subdomains of the ZAP-70 kinase 
domain.   
1.7.5 ZAP­70 in development and disease A spontaneous occurring single amino acid substitution in the second SH2‐domain (W163C) alters TCR‐mediated  signaling,  the  outcome  of  thymic  selection  and  causes  joint  inflammation  and infiltration of CD4+ T‐cells in these animals, which is strongly reminiscent of rheumatoid arthritis in humans (84). If those mice are crossed with HY TCR‐transgenic mice, male‐specific thymocytes that are positively selected in non‐transgenic female animals, fail to become CD8+ SP T‐cells. In contrast, thymocytes that would be negatively selected in male animals develop to some degree into CD8+ SP T‐cells,  which  points  towards  an  altered  threshold  of  thymic  selection.  Since  the  described  point mutation affects the SH2 domain and therefore binding to phosphorylated ITAMs, one explanation for the altered thymocyte selection may be that high‐affinity TCR signals would be weakened due to reduced  ZAP‐70  recruitment  to  activated  TCR  complexes.  On  the  other  hand,  low‐affinity  TCR signals  would  be  reduced  to  non‐selecting  levels  due  to  inefficient  recruitment  and  subsequent activation of ZAP‐70.  In  patients  with  selective  T‐cell  deficiency  (STD),  who  are  characterized  by  persistent  infections reminiscent  of  severe  combined  immunodeficiency,  a  DNA  point  mutation  leads  to  alternative splicing of the zap­70 gene (85). This results in a three amino acid insertion in the kinase that has no detectable  enzymatic  activity.  T‐cells  from  three  patients,  homozygous  for  the  zap­70  gene mutation,  exhibit  markedly  reduced  tyrosine  phosphorylation.  However,  some  Ca2+  mobilization 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remains  in activated peripheral T‐cells,  likely due  to Fyn kinase  that has more  redundant ZAP‐70 functions  in  humans  than  in  mice.  In  contrast,  ZAP‐70  activity  is  indispensable  for  the  positive selection  of  CD8+  SP  thymocytes.  These  observations  underline  the  essential  role  of  ZAP‐70  in thymic selection, whereas peripheral T‐cells exhibit some independency of ZAP‐70 in TCR‐mediated signaling. Another  study demonstrates  that a  spontaneously occurring point mutation  in  the DLAARN motif (R464C)  of  ZAP‐70’s  kinase  domain  (in  fact  DLAARN  is  conserved  among  all  PTKs),  results  in defective TCR signaling and a complete arrest of thymocyte development at the CD4+ CD8+ DP stage (77).  These  mice  express  a  catalytically  inactive  form  of  ZAP‐70,  again  demonstrating  the requirement for ZAP‐70 activity in thymocyte development.  In healthy  individuals, ZAP‐70 expression is restricted to T‐cells and NK cells. However, ZAP‐70 is expressed  in peripheral B‐cells of  the majority of poorer prognosis  chronic  lymphocytic  leukemia (CLL)  patients  (with  unmutated  IgVH  genes,  showing  98  –  100%  homology  to  the  germline sequence),  but  absent  in  most  cases  with  mutated  IgVH  genes  (reviewed  in  (86)).  This overexpression has functional consequences in CLL, although it is not clear whether this reflects the ongoing of transforming events or whether ZAP‐70 expression is a consequence of a more activated B‐cell  type  (there  is  some  evidence  that  ZAP‐70  expression  is  induced  in  B‐cell  progenitors  and activated B‐cells).  





2.1.1 For molecular techniques XL‐1blue competent bacteria  Stratagene Ampicillin  Sigma Primers  Microsynth  
2.1.2 For cellular techniques 
β‐mercaptoethanol (β‐me)  Gibco RPMI  Gibco DMEM  Gibco Fetal calf serum (FCS)  Amimed Non‐essential amino acids (100x)  Gibco Sodium pyruvate (100x)  Gibco Penicillin‐streptavidin (100x)  Gibco L‐glutamine (100x)  Gibco Polybrene  Sigma Hygromycin B  Calbiochem Geneticin (G418)  Sigma Puromycin  Sigma L‐histidinol  Sigma 




2.1.3 For biochemical techniques Protease inhibitor cocktail (+EDTA)  Sigma Protein G sepharose  GE Healthcare Trans‐Blot nitrocellulose membrane  Bio‐Rad Dual color protein standard  Bio‐Rad Acrylamide/Bis 30:1 solution  Bio‐Rad Amonium persulfate (APS)  Bio‐Rad N,N,N’,N’‐Tetramethylethylenediamine (TEMED)  Bio‐Rad Ponceau red  Sigma Skim milk powder  Bio‐Rad ECL Western blotting detection reagents  GE Healthcare (Amersham Biosciences) Hyperfilm ECL  GE Healthcare (Amersham Biosciences) LAT, recombinant protein  Millipore ATP  Sigma  
2.1.4 Enzymes AccuPrime DNA polymerase  Invitrogen Restriction Enzymes and buffers  New England Biolabs Shrimp alkaline phosphatase  Roche  
2.1.5 Kits DNA Maxi Prep kit  Qiagen DNA Mini Prep kit  Qiagen Gel extraction kit  Qiagen T4 DNA ligase kit (Ready To Go)  Amersham Biosciences ABI Prism DNA sequencing kit  Applied Biosystems Slowfade anti‐fade kit  Invitrogen  
2.2 Solutions and media 
2.2.1 For molecular techniques 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TAE  40mM  Tris‐acetate pH 8.0   1mM  EDTA  DNA loading buffer (5x)    H2O     30% glycerol   0.25%  Bromphenol blue   0.25%  Xylene cyanol  TE  10mM  Tris pH 8.0   1mM  EDTA  
2.2.2 For biochemical techniques Lysis Buffer    H20   1%  Brij 58 or Nonidet P‐40   50mM  Tris pH 7.5   15mM  NaCl   1mM  PMSF   1mM  Sodium orthovanadate, activated   1mM  NaF   1mM  β‐glycerophosphate   1x  Protease inhibitor cocktail (+EDTA)  IP wash buffer  ±0.5%  Brij 58 or Nonidet P‐40   50mM  Tris pH 7.5   15mM  NaCl  Kinase assay buffer  50mM  Tris pH 7.5   30mM  NaCl   5mM  MgCl2   10mM  ATP  
2.2.3 For SDS­Page and Western blotting Separating gel    H2O   10% ‐ 12%  30% Acrylamide/Bis 30:1 solution   375 mM  Tris pH 8.8 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 0.1%  SDS   0.1%  APS   0.01%  TEMED  Stacking gel    H2O   5%  30% Acrylamide/Bis 30:1 solution    250 mM  Tris pH 6.8   0.1%  SDS   0.1%  APS   0.01%  TEMED  SDS running buffer  25mM  Tris pH 8.0   250mM  Glycine   0.1%  SDS  SDS loading buffer (5x)  50mM  Tris pH 6.8   20%  Glycerol   2%  SDS   5%  β‐me  Transfer buffer  25mM  Tris pH 8.0   250mM  Glycine   20%  Methanol  TBS  50mM  Tris pH 7.6   0.9%  NaCl  TBS‐T    TBS   0.1%  Tween 20  Blocking buffer    TBS‐T   5%  Skim milk powder   0.02%  NaN3  
2.2.4 For cellular techniques PBS  137mM  NaCl 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 2.7mM  KCl   8.0mM  Na2HPO4   1.5mM  KH2PO4  FACS buffer    PBS   1%  FCS   0.2%  NaN3  LB medium  1%  Bacto‐tryptone   0.5%  Bacto‐yeast extract   90mM  NaCl  LB freezing medium    LB medium   15%  glycerol  LB agar plates    LB medium   1.5%  Agar     autoclaved, selective drug added if required   
2.2.5 Media used for cell culture Basic medium    RPMI or DMEM   100U/ml  Penicillin   100µg/ml  Streptomycin   2mM  L‐glutamine   1mM  Non‐essential amino acids   1mM  Sodium pyruvate   5mM  β‐me  58 hybridoma medium    RPMI basic medium   4%  FCS  APC medium    RPMI or DMEM basic medium   8%  FCS  T‐cell medium    DMEM basic medium   10%  FCS 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FTOC medium    DMEM basic medium   10%  FCS   5mg/ml  β2m  
2.2.6 Instruments Biometra Thermocycler T3  Chatel‐St. Denis, Switzerland ABI Prism 310 Genetic Analyzer  Applied Biosystems Inc., USA Ultracentrifuge Optima L‐90K  Beckman Coulter Inc., USA High‐Speed Centrifuge Avanti J‐25  Beckman Coulter Inc., USA Table Top Centrifuge 5417R  Eppendorf AG, Germany Multifuge 3 S‐R  Heraeus Holding GmbH, Germany Spectrophotometer SpectraMAX 250  MDS Analytical Technologies Inc., USA Thermomixer 5436  Eppendorf AG, Germany Water bath TW12  Julabo Labortechnik GmbH, Germany Flow cytometer Cyan II  Dako Denmark S/A, Denmark inFlux cell sorter  Cytopeia Inc, USA Magnetic cell sorter AutoMACS  Miltenyi Biotech, Germany Olympus IX‐81 fluorescence microscope  Olympus AG, Switzerland MT‐20 Illumination unit  Olympus AG, Switzerland Film Developer Curix 60  Agfa‐Gevaert AG, Switzerland Densitometer Gel Doc 2000  Bio‐Rad Laboratories Inc., USA  
2.2.7 Software Program  Application  Provider  MacVector  DNA alignments  Accelrys Inc., USA Summit  FACS acquisition  Dako Denmark S/A, Denmark FlowJo  FACS analysis  Tree Star Inc., USA SoftMax Pro  Spectro‐photometry  GraphPad Software Inc., USA Prism  Graphs, calculations  GraphPad Software Inc., USA CellR  Image acquisition  Olympus AG, Switzerland ImageJ  Image analysis, FRET  NIH, USA Quantity One  Densitometry  Bio‐Rad Laboratories Inc., USA Illustrator  Graphics, Layout  Adobe Systems Inc., USA 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Photoshop  Images  Adobe Systems Inc., USA InDesign  Document Preparation, Layout  Adobe Systems Inc., USA Keynote  Presentations  Apple Computer Inc., USA  
2.2.8 Antibodies Antigen  Clone  Reference  Provider  
α‐mouse CD3ε  (145‐2C11)  (87, 88)  BD Biosciences 
α‐mouse CD3ζ  (H146‐968)  (89)  BD Biosciences 
α‐mouse TCR‐Cβ  (H57‐597)  (88)  BD Biosciences 
α‐mouse TCR Vα2  (B20.1)    BD Biosciences 
α‐mouse TCR Vβ5  (MR9‐4)    BD Biosciences 
α‐mouse CD4  (RM4‐5)    BD Biosciences 
α‐mouse CD8α  (53‐6.7)    BD Biosciences 
α‐mouse CD8β  (53‐5.8)    BD Biosciences  
α‐mouse ZAP‐70  (99F2)  (78)  Cell Signaling 
α‐mouse ZAP‐70  (clone 29)  (79)  BD Biosciences 
α‐mouse ZAP‐70 pTyr319  (65E4)  (78)  Cell Signaling 
α‐mouse ZAP‐70 pTyr493  (2704)  (78)  Cell Signaling 
α‐mouse LAT  (rabbit polycl.)  (43, 90)  Upstate  
α‐mouse IL‐2 (capture)  (JES6‐IAI2)    eBioscience 
α‐mouse IL‐2 (detect)  (JES6‐5H4)    eBioscience 
α‐mouse CD69  (H1.2F3)    BD Biosciences 
α‐mouse NK1.1  (PK136)    BD Biosciences 
α‐mouse CD19  (1D3)    BD Biosciences 
α‐mouse H‐2Kb  (AF6‐88.5)  (37)  BD Biosciences  
α‐Phospho tyrosine  (4G10)    Upstate 
α‐GFP (rabbit monocl.)  (E385)    Epitomics 
α‐GFP (mouse monocl.)  (B‐2)    Santa Cruz Biotech.  
38 
 
2.2.9 Peptides OVA variant peptides were synthesized and purified as described (91) (92) and had the  following affinity hierarchy for the OT‐I TCR: OVA > Q4 > Q4R7 > T4 > Q4H7 > G4 > E1 >> VSV (8).  Sequence  Abbreviation  Selection in OT‐I wt FTOC  SIINFEKL  OVA  neg. SIIQFEKL  Q4  neg. SIIQFERL  Q4R7  neg. SIITFEKL  T4  border (not used in these studies) SIIQFEHL  Q4H7  pos. SIIGFEKL  G4  pos. EIINFEKL  E1  pos. RGYVYQGL  VSV  null (non‐cognate)  
2.2.10 Expression vectors Name  Retro/Lenti  Selection Marker  Source/Reference  LXSN  Retro  Geneticin (G418)  (33) LXSP  Retro  Puromycin  (33) pMFG  Retro  CFP/YFP  (93) pTRIP∆U3EF1αEGFP  Lenti  GFP  N. Taylor, Montpellier  
2.3 cDNA sequences The  OT‐I  TCR  comprises  rearranged  TCRα  (Vα2‐Jα26)  and  TCRβ  (Vβ5‐Dβ2‐Jβ2.6)  chains  and  is derived from the Kb‐restricted, OVA257‐264‐specific CTL clone, 149.42 (94). The cDNAs encoding the OT‐Iα  and  OT‐Iβ  wildtype  chains  were  recovered  by  standard  PCR  techniques  from  retroviral vectors  described  earlier  (95).  cDNAs  encoding  the OT‐I αδ  chimeras were  constructed  using  the previously described II and IV chimeric cDNAs (33) encoding the 3BBM74 TCR (96). Similarly,  the OT‐I βγ chimera III was constructed by replacing the XbaI‐XhoI fragment of the OTI β‐chain with the corresponding chimeric βIII fragment (33).  










2.4 DNA constructs The  cDNAs  encoding  the  OT‐I  α  and  OT‐I  β  wildtype  chains  were  recovered  by  standard  PCR techniques from retroviral vectors described earlier (95) and ligated into the BamHI and XhoI sites of the lentiviral expression vector pTRIP∆U3EF1αEGFP, replacing the BamHI‐EGFP‐XhoI  fragment. Resulting  plasmids  were  referred  to  as  pTRIP∆U3EF1α‐OTIα  and  pTRIP∆U3EF1α‐OTIβ, respectively. The OT‐I αδ chimeric chains were constructed by replacing the SpeI‐XhoI fragment of pTRIP∆U3EF1α‐OTIα  with  the  corresponding  fragment  from  the  αII  or  αIV  chimeric  α‐chain, respectively. Similarly, the OT‐I βγ chimera III was constructed by replacing the XbaI‐XhoI fragment of pTRIP∆U3EF1α‐OTIβ with the corresponding chimeric βIII fragment.  To recover the OT‐I α and OT‐I β wildtype chains and introduce the BamHI and XhoI restriction sites the following primers were used:  OT‐I α‐chain forward:  5’‐CGAACGGATCCATGGACAAGATTCTGACAGCAAC‐3’ OT‐I α‐chain reverse:  5’‐CCTTGCTCGAGTCAACTGGACCACAGCCTCAG‐3’  OT‐I β‐chain forward:  5’‐GGTTCGGATCCATGTCTAACACTGTCCTCGCTG‐3’ OT‐I β‐chain reverse:  5’‐CGAAGCTCGAGTCATGAGTTTTTTCTTTTGACCATA   GCC‐3’ 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2.5 Cell lines Name  Description  Source/Reference  TSA/293T  Fibroblast derived from HEK293  S. Treves, Basel Phoenix  Fibroblast derived from 293T  G. Nolan, Stanford RMA‐S‐Kb  RMA‐S transfected with H‐2Kb  (37, 97) P1.32‐Kb  P‐815 transfected with H‐2Kb  (95) 3LBM 13.1 (bm12)  Antigen presenting cell, H‐2Kb expressing 58 hybridoma  TCR‐ CD4‐/CD8‐ hybridoma  (98) 58 OTI.ZC.8bY  58 hybridoma transfected with OT‐I wildtype   TCR, ζ‐CFP, CD8α and CD8β‐YFP  (4) 58 sw3.ZC.8bY  58 hybridoma transfected withOT‐I α‐CPM   mutant TCR, ζ‐CFP, CD8α and CD8β‐YFP  (4) 58 sw4.ZC.8bY  58 hybridoma transfected with OT‐I TM    control TCR, ζ‐CFP, CD8α and CD8β‐YFP  (4)  
2.6 Molecular techniques 
2.6.1 Transformation of competent bacteria 10ng  of  plasmid  DNA  or  ligation  mix  was  added  to  50ml  of  XL‐1blue  competent  bacteria  and incubated on ice for 30min, followed by incubation at 42°C for 90sec and cooling down on ice. Upon addition of 800µl LB medium (no antibiotics!), bacteria were kept at 37°C for 1h before plating on LB agar plates containing 50mg/ml ampicillin. Plates were incubated at 37°C overnight.  
2.6.2 Plasmid preparation 2ml of LB broth containing 50mg/ml ampicillin was  inoculated with a  transformed bacteria clone and  incubated  on  a  shaker  (280rpm)  at  37°C  for  6‐12h.  Depending  on  the  scale  of  preparation, bacteria cultures were directly used for plasmid preparation (Miniprep) or to inoculate 500ml of LB broth‐ampicillin (Maxiprep). For Maxiprep, the 500ml culture was allowed to grow until OD600nm of 0.4‐0.5  was  reached,  representing  the  transition  from  exponential  into  stationary  growth  phase. Bacteria were  harvested  by  centrifugation  at  6000xg  for  15min  at  4°C.  Plasmid  preparation was carried out according  to  the manufacturer’s protocol  (Qiagen). Concentration of purified plasmids was estimated by measuring OD260nm and adjusted to 1mg/ml with TE buffer. 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2.6.3 PCR 1ng of DNA was used as template for PCR. Primers were used at a final concentration of 0.3µM. The AccuPrime  DNA  polymerase  was  utilized  according  to  the  manufacturer’s  recommendations (Invitrogen). PCRs were carried out  in a  total volume of 50ml  in thin‐walled 0.5ml reaction tubes, using the T3 thermocycler.  
2.6.4 Restriction enzyme digestion of plasmid DNA Restriction digests were carried out  for 1h at 37°C using 1µg of plasmid DNA in a  total volume of 40ml.  The  appropriate  buffer  was  chosen  according  to  the  manufacturer’s  recommendations (Promega) and BSA was added to 100µg/ml if specified. Upon incubation, 10ml TAE loading buffer was  added  and  DNA  fragments  were  resolved  on  a  1.2‐2%  agarose  gels  containing  ethidium bromide.  Appropriate  sized  DNA  fragments were  excised  from  the  gel  and  purified  using  the  gel extraction kit and the manufacturer’s protocol (Qiagen).  
2.6.5 DNA ligation DNA  ligations were  carried  out  for  30min  at  16°C using 100ng of  vector DNA and 10ng  of  insert DNA in a total volume of 20ml. The enzyme and the appropriate buffer are provided in the T4 DNA ligase kit (Amersham Biosciences). Upon ligation, 1‐10µl of the reaction mix was used to transform XL‐1blue competent bacteria.  
2.6.6 DNA sequencing DNA constructs were sequenced using the ABI Prism BigDye Terminator v3.0 Ready Reaction Cycle Sequencing  kit  and  the ABI  Prism 310 Genetic  Analyzer.  600‐700ng DNA  template was  used  and 10µM  specific  primers  (Microsynth).  PCR  reaction  mix  (including  DNA  polymerase),  sequencing controls and thermal cycling was used according to the manufacturer’s recommendations (Applied Biosystems).  
2.7 Cellular techniques 
2.7.1 Production of lentivirus Lentivirus was  produced  in  a  biolevel  2  facility.  All  the DNA plasmids were  at  a  concentration  of 1mg/ml. 2x106 TSA fibroblast cells were seeded per 10cm plate in 6.5ml DMEM medium containing 10% FCS. Upon reaching 60‐70% confluency, the cotransfection mastermix is prepared, containing 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8.6µg  gag/pol  plasmid,  2.8µg  env  plasmid  (ecotropic  vsv‐g)  and  8.6µg  vector  plasmid  in  a  total volume of 20µl. 500µl HBS pH 7.00 and 33µl 2M CaCl2 (both filtered 0.2mm) were added followed by  immediate  vortexing  for  10sec.  Subsequently  the  cotransfection  mastermix  was  dropwise supplied  to  the  plate.  14h  after  transfection, medium was  exchanged with  6.5ml  DMEM 2%  FBS. Virion  production  was  allowed  for  24‐30h.  Supernatants  were  filtered  with  a  0.45µm  filter  and virions  were  concentrated  by  ultracentrifugation  for  2h  at  25.000rpm  at  4°C,  using  the  SW28 Beckman  rotor.  The  virion  pellet  was  resuspended  in  100µl  RPMI  1%  BSA  (filtered  0.2mm)  and aliquots were frozen at ‐80°C.  
2.7.2 Production of retrovirus 2x106 phoenix  fibroblast  cells were  seeded per 10cm plate  in 7ml DMEM medium containing 8% FCS.  Upon  reaching  70‐80%  confluency,  10µg  vector  plasmid  and  10µg  IPK6  ecotropic  helper plasmid  (encoding  the  accessory  viral  genes) were  adjusted  to  300µl  with  DMEM.  80µl  PolyFect transfection reagent was added and the transfection mix was vortexed for 10sec and incubated for 5min  at  room  temperature.  In  the meantime,  the  phoenix  cell  medium was  exchanged with  5ml fresh DMEM 8% FCS. Then, the transfection mix was combined with 1ml fresh DMEM 8% FCS and dropwise  supplied  to  the  plate.  Virion  production  was  allowed  for  24‐30h.  Supernatants  were filtered with a 0.45µm filter and virions were concentrated by centrifugation for 1h at 14.000rpm at 4°C in 2ml eppendorf tubes. Upon centrifugation, the upper 50% of medium were aspirated and the remaining viral supernatant was immediately used for transduction.  




2.7.4 Fluorescence activated cell sorting (FACS) Staining with fluorescence labeled monoclonal antibodies was performed in FACS buffer for 20min on ice. All antibodies were titrated and used at a concentration that corresponds to saturation of the antibody  binding  curve.  Upon  staining,  cells  were washed  twice  in  FACS  buffer  and  subjected  to analysis on a Cyan II flow cytometer using the Summit software. If required, PI staining to exclude dead cells was performed directly before flow cytometry analysis.  
2.7.5 RMA­S peptide loading 
Tap2  deficient  RMA‐S  cells  were  loaded  with  exogenous  OVA  peptide  variants.  The  loading concentration of each peptide was varied to generate similar peptide‐H‐2Kb expression (4). Prior to peptide addition, RMA‐S cells were incubated at 29°C overnight. If required, the cells were stained with Cy5 mono‐reactive dye for 5min at room temperature and washed once. Peptide loading was carried out for 30min at 29°C and 3h at 37°C. pMHC surface expression was assessed by anti‐H‐2Kb staining and flow cytometry analysis.  
2.7.6 Conjugate formation assay 2.5 x105 OT‐I hybridomas and 2.5 x105 peptide‐loaded, Cy5‐labeled RMA‐S cells (each in 50µl) were incubated  in  flat‐bottomed  wells  at  37°C.  To  stop  the  stimulation,  cells  were  fixed  with  2% formaldehyde  at  various  time  points.  Upon washing,  cells were  analyzed  by  flow  cytometry.  The percentage  of  CD8β‐YFP  (=  OT‐I  hybridomas)  and  Cy5  (=RMA‐S)  double  positive  conjugates was compared to the total number of CD8β‐YFP positive cells at each time point.  
2.7.7 TCR endocytosis 2.5 x105 OT‐I hybridomas and 2.5 x105 peptide‐pulsed RMA‐S cells (each in 50µl) were incubated in flat‐bottomed wells at 37°C. To stop the stimulation, cells were fixed with 2% formaldehyde. Upon washing,  staining  with  monoclonal  antibodies  for  Vβ5  and  flow  cytometry  analysis  revealed  the percentage of TCRs remaining on the cell surface of CD8β‐YFP positive cells (= OT‐I hybridomas) at each time point. 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2.7.8 IL­2 detection by ELISA 96‐well  flat‐bottomed ELISA plates (Nunc MaxiSorp) were coated with 60µl  capturing anti‐IL‐2 at 2µg/ml in PBS 0.02% NaN3 overnight at 4°C. For antigen stimulation, 105 OT‐I hybridomas and 105 peptide‐pulsed RMA‐S cells (each in 100µl) were incubated in flat‐bottomed wells for 24h at 37°C. 100µl  of  the  supernatant  was  added  to  the  washed  and  blocked  ELISA  plates  for  1h  at  room temperature.  Detecting  anti‐IL‐2‐biotin  was  applied  at  2µg/ml  for  1h  at  room  temperature. Streptavidin‐HRP  was  applied  at  0.3µg/ml  for  1h  at  room  temperature.  Conversion  of  0‐phenylenediamine  dihydrochloride  was  allowed  for  5min  in  the  dark  followed  by  stopping  the reaction with 50µl 10% H2SO4 per well. OD490nm was detected and normalized to a standard dilution series by the Softmax Pro software.  
2.7.9 Stimulation of T­cell hybridomas for FRET microscopy 2.5 x105 OT‐I hybridomas and 2.5 x105 peptide‐pulsed, Cy5‐labeled RMA‐S cells (each in 50µl) were incubated  in  flat‐bottomed  wells  at  37°C.  Stimulation  was  stopped  by  fixation  with  2% formaldehyde.  Cells  were  washed  with  PBS,  10mM  Tris  pH  7.5  and  finally  with  buffer  C  of  the Slowfade antifade kit. Cells were mounted on standard glass slides  in Slowfade antifade mounting medium and sealed with nail polish.  
2.7.10 FRET microscopy An Olympus  IX81  inverted microscope was  used  to  acquire  the  fluorescence  images  required  for FRET. A triggered F‐View II camera was attached to the microscope and the MT20 illumination unit with  a  150W  Xenon  lamp.  The  system was  run  by  the  CellR  software.  Optical  filter  cubes  on  an automated  turret  were  used  to  change  excitation  and  emission  corresponding  to  the  various channels.  The  filter  cubes  had  the  following  spectral  specifications  (center/bandpass):  YFP excitation,  500/20nm;  YFP  emission,  535/30nm;  CFP  excitation,  436/20nm;  CFP  emission, 480/40nm. The FRET filter cube was a combination of the CFP excitation filter and the YFP emission filter. Beamsplitting was achieved with a 455nm long pass dichroic mirror in the CFP filter cube and with  a  515nm  long  pass  dichroic mirror  in  the  YFP  and  FRET  filter  cubes.  A  60x,  1.4−numerical aperture oil objective was used for all images.  
2.7.11 FRET analysis For CFP and YFP, the efficiency of energy transfer is greater than 50% within the Förster Radius R0 of  4.9  ‐  5.2  nm  and  approximates  zero  beyond  2x  R0  (~10nm).  Crosstalk  coefficients  of  CFP 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fluorescence into the FRET channel (=d) and YFP into the FRET channel (=a) were calibrated using hybridomas transfected with either CD3ζ‐CFP or CD8β‐YFP alone. For the specified filter cubes they were d=36.8% and a=18.1%. For each image, the CFP, YFP and FRET channel was acquired using the 3 specified  filter cubes. Background was subtracted as averaged signal  from a user‐specified,  cell‐free  region  of  each  image.  To  calculate  the  FRET  efficiency  the  following  formula  was  used:  E  = (FRET ‐ a·CFP ‐ d·YFP)/(FRET – a·CFP – d·YFP + G ·CFP), which was described earlier (36) (99). G is the  independently  calibrated  ratio  of  sensitized  emission  in  the  FRET  channel  before photobleaching to donor recovery in the CFP channel after acceptor photobleaching (100). For the imaging  system  used  here,  G  =  1.7  ±  0.1.  FRET  efficiencies were  calculated  from  hybridoma:APC interfaces.  For  illustration,  the  ImageJ  software  was  used  and  calculated  FRET  efficiency  images were depicted in pseudo‐colors. Statistical analysis of E was performed using Student’s two‐sample t‐test  assuming  two‐tailed  distribution  and  unequal  variance.  The  recruitment  of  fluorescently tagged  proteins  to  the  synapse  was  calculated  as  background‐corrected  ratio  of  the  MFI  of  the synapse region divided by the MFI of a user‐defined membrane region, outside of the synapse.   
2.7.12 Isolation of B­cells from spleen Splenocytes  from  C57  Bl/6 mice  were  subjected  to  red  blood  cell  lysis  by  incubation  in  H2O  for 10sec followed by addition of 10x PBS. Upon washing, cells were kept in staining buffer consisting of 50% T‐cell medium, 50% PBS and 2mM EDTA. Staining with FITC‐labeled anti‐CD8α, anti‐CD4 and anti‐NK1.1 was allowed  for 15min on  ice. Upon washing, MACS anti‐FITC microbeads were added for  10min  on  ice.  After  another  washing  step,  the  ‘Depletion  S’  program  of  the  AutoMACS  cell isolator (Miltenyi Biotec) was executed and non‐FITC‐labeled cells were collected. Flow cytometry analysis revealed that the vast majority of the collected cells were positive for CD19 and negative for CD8α, CD4 or NK1.1.   
2.7.13 Stimulation of thymocytes and immunostaining for fluorescence microscopy B‐cells  isolated  from  C57  Bl/6 mice were  stained with  Cy5 mono‐reactive  dye  for  5min  at  room temperature  and  washed  once.  Peptide  loading  was  carried  out  with  2µM  exogenously  added specific peptide for 2h at 37°C in T‐cell medium. Then, 2.5 x105 thymocytes from OT‐I Rag‐/‐ β2m‐/‐ transgenic mice and 2.5 x105 peptide‐loaded B‐cells and were pulse spinned at 3.000rpm for 20sec and incubated at 37°C. Stimulation was stopped by putting the tubes on ice. Cells were allowed to adhere on (3‐Aminopropyl)triethoxy‐silane coated cover slips  for 10min on  ice before being  fixed with 2% formaldehyde for 1h at room temperature. Upon washing, cells were permeabilized with PBS 0.2% Triton X‐100 for 2min on ice and blocked with PBS 3% BSA for 1h at room temperature. Staining with  primary  antibodies was  carried  out  in  PBS  1.5%  BSA  for  1h  at  room  temperature. 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Upon washing,  fluorescence labeled secondary antibodies were applied in PBS 1.5% BSA for 1h at room  temperature.  After  washing,  the  cover  slips  were  mounted  on  microscopy  glass  slides  in FluorSave  reagent. Microscopy was  performed  using  the  Olympus  IX81  fluorescence microscope. The  recruitment  of  fluorescently  tagged  proteins  to  the  synapse  was  calculated  as  background‐corrected  ratio  of  the MFI  of  the  synapse  region divided by  the MFI  of  a  user‐defined membrane region, outside of the synapse.  
2.7.14 Fetal thymic organ culture (FTOC) FTOC was performed as described (101). In brief, thymic lobes were excised from OT‐I Rag‐/‐ β2m‐/‐ transgenic  mice  at  a  gestational  age  of  day  15.5.  FTOCs  included  exogenous  β2m  (5µg/ml)  and peptide  (2µM  for  negative‐selecting  and  20µM  for  positive  selecting  peptides).  After  7  days  of culture, thymocytes were subjected to flow cytometry analysis.  
2.8 Biochemical techniques 
2.8.1 Fixation of APCs Peptide‐loaded  APCs  were  kept  at  6  x107  cells/ml  in  T‐cell  medium  at  37°C.  Prewarmed glutaraldehyde was  added  to  0.1%  for  30sec.  Fixation was  stopped  by  adding  lysine  to  0.2%  for 10min  at  room  temperature.  Cells  were  washed  three  times  with  PBS  and  adjusted  to  6  x  107 cells/ml in T‐cell medium.   
2.8.2 Immunoprecipitation and Western blot 3 x107  thymocytes  from OT‐I Rag‐/‐ β2m‐/‐  transgenic mice and 3 x107 peptide‐loaded,  fixed APCs (both in 500ml) were pulse spinned at 3.000rpm for 20sec and incubated at 37°C. Stimulation was stopped by putting the tubes on ice. Cells were lysed in 500µl lysis buffer containing 1% detergent and incubated for 15min on ice. Cell lysates were cleared by centrifugation at 14.000rpm for 10min at  4°C.  Immunoprecipitation  was  performed  with  1µg  of  monoclonal  antibody  and  20µl  of  80% protein G  sepharose  for  a  total  of  2.5h  on  a  rotator  at  4°C. Upon washing,  sepharose  beads were boiled  with  10µl  SDS‐containing,  reducing  sample  buffer  for  5min  at  95°C  and  SDS‐PAGE  and Western  blotting  was  performed.  Protein  transfer  to  nitrocellulose  membranes  was  checked  by ponceau red staining before the membranes were treated with blocking buffer. Primary antibodies were applied in TBS‐T 5% BSA 0.02% NaN3 and binding was allowed either over night at 4°C or 1h at  room  temperature.  Upon  washing  with  TBS‐T,  HRP‐conjugated  secondary  antibodies  were applied  in  TBS‐T  3%  BSA  for  30min  at  room  temperature.  After  washing,  the  membranes  were 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incubated  for  1min  in  1ml  reagent  1  combined  with  1ml  reagent  2  of  the  ECL  western  blotting detection  reagents.  Chemiluminescence  of  HRP‐mediated  conversion  of  the  detection  reagent (luminol) was captured by exposing  the membranes  to ECL hyperfilms  for appropriate periods of time and developing the films on a Curix80 developer.   
2.8.3 ZAP­70 in vitro kinase assay ZAP‐70 was immunoprecipitated from activated TCR complexes like described above, using the α‐mouse  CD3ε  antibody  and  1%  Brij  58  in  the  lysis  buffer.  Upon  immunoprecipitation,  sepharose beads  were  2x  equilibrated  in  kinase  assay  buffer.  0.5µg  recombinant  LAT  was  added  to  each sample and incubation was carried out for 10min at 37°C under constant agitation (1.000rpm). SDS‐PAGE  and Western  blotting was  performed  as  described  above.  Tyrosine  phosphorylation  of  the recombinant  LAT  reporter  was  either  shown  with  anti‐phosphotyrosine  (4G10)  or  specific  anti‐phosphoLAT antisera. 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3.2  A  discrete  affinity  driven  elevation  of  ZAP­70  activity  distinguishes  positive  and 
negative selection Manuscript in preparation  Michel Mallaun, Gerhard Zenke and Ed Palmer    
3.2.1 Summary  By  directly  binding  to  the  CD3  molecules  of  the  T‐cell  receptor  (TCR)  complex,  the  ζ‐chain associated protein of 70 kDa (ZAP‐70) plays a central role in proximal TCR signaling. Once the TCR is  binds  antigenic  peptide‐MHC  (p‐MHC)  ligands,  the  CD3 molecules  are  tyrosine  phosphorylated allowing ZAP‐70 to bind and propagate the signal to downstream signaling molecules. It is unclear to what extend ZAP‐70 is recruited to engaged TCRs in response to varying p‐MHC‐TCR interactions, such  as  in  thymic  selection. Using OT‐I  transgenic  double‐positive  (DP) pre‐selection  thymocytes, we  studied  the  recruitment of ZAP‐70  to  the  immunological  synapse and  its phosphorylation at  a regulatory and an activating tyrosine residue. The strong recruitment and phosphorylation of ZAP‐70  in  response  to  negative  selecting  ligands  correlated with  an  approximately  2‐fold  increase  in ZAP‐70  kinase  activity  compared  to  positive  selecting  ligands.  Positive  selectors  failed  to  recruit high  levels  of  ZAP‐70  into  the  synapse,  although we  found  that  recruited molecules were  in  fact phosphorylated, which induced moderate ZAP‐70 kinase activity. Furthermore, we show that ZAP‐70 kinase activity is a determinant of thymic selection outcome. By partial inhibition ZAP‐70 kinase activity, negative selection can be converted into positive selection. Using the same ZAP‐70 kinase inhibitor, we also show that phosphorylation of tyrosine 493 in the kinase activation loop is mostly mediated by ZAP‐70 auto‐phosphorylation, whereas phosphorylation of the regulatory tyrosine 319 depends  on  kinases  other  that  ZAP‐70.  The  2‐fold  increase  in  ZAP‐70  recruitment  above  the negative  selection  threshold  can  be  explained  by  a  similar  increase  in  TCR  recruitment  to  the synapse and is not due to an increased relative ZAP‐70 / TCR ratio. Therefore, we hypothesize that the TCR by binding to ligands of varying affinity, recruits associated ZAP‐70 proportionally, thereby determining  the  amount  of  ZAP‐70  kinase  activity.  Negative  selection  is  only  induced  if  ZAP‐70 kinase activity is elevated 2‐fold over positive selection. 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3.2.2 Introduction  Following αβ T‐cell  receptor  (TCR) engagement by pMHC  ligands,  the Syk  family protein  tyrosine kinase  (PTK)  ZAP‐70  is  activated  and  phosphorylates  several  downstream  target  molecules  (63, 102,  103).  ZAP‐70  initially  binds  to  phosphorylated  immunoreceptor  tyrosine‐based  activation motifs  (ITAMs) of  the ζ  and CD3ε  subunits of  the TCR complex  through  its  tandem Src‐homology region 2 (SH2) domain (70, 104). Subsequently, ζ‐bound ZAP‐70 is tyrosine phosphorylated (78, 81, 105). ZAP‐70 is a key signaling component in thymocytes since ZAP‐70 deficient mice are blocked in both positive and negative selection (64).  Studies  have  shown  that  ZAP‐70 dysfunction  can  lead  to  autoimmunity. A  spontaneous  occurring single amino acid substitution  in  the second SH2‐domain (W163C) alters TCR‐mediated signaling, the  outcome  of  thymic  selection  and  causes  joint  inflammation  and  infiltration  of  CD4+  T‐cells,  a pathology reminiscent of rheumatoid arthritis in humans (84). Apparently, the efficiency of negative selection  is altered  in  these mutant mice due  to  the reduction of ZAP‐70 activity.  In patients with selective  T‐cell  deficiency  (STD),  who  suffer  from  persistent  infections  reminiscent  of  severe combined immunodeficiency, a point mutation leads to alternative splicing of the zap­70 gene (85). This mutation results in a three amino acid insertion in the kinase domain, abolishing its enzymatic activity.  T‐cells  from  patients,  homozygous  for  this  point  mutation  exhibit  markedly  reduced tyrosine phosphorylation; nevertheless  some Ca2+ mobilization  remains  in activated peripheral T‐cells. The authors suggest that the Src kinase Fyn takes over some ZAP‐70 functions in peripheral T‐cells. On the other hand, ZAP‐70 deficiency in mice blocks both positive and negative selection of DP thymocytes (64). Another study demonstrates that a spontaneously occurring point mutation in the DLAARN motif (R464C) of ZAP‐70’s kinase domain results in defective TCR signaling and a complete arrest of  thymocyte development at  the DP stage  (77). These mice express a  catalytically  inactive form  of  ZAP‐70,  again  demonstrating  the  requirement  for  ZAP‐70  activity  in  thymocyte development. The number of CD3 ITAMs and by the extension the quantity of ZAP‐70 kinase activity seems to play a central role in the establishment of central tolerance. In transgenic mice expressing either class I or  class  II  MHC  restricted  TCRs,  the  percentage  of  positively  selected  CD8+  or  CD4+  SP  cells, respectively,  decreases  by  reducing  the  number  of  ζ–chain  ITAMs  (73).  This  change  of  ITAM multiplicity  alters  the efficiency of  thymic  selection by  reducing ZAP‐70 binding and downstream signaling.  Another  study  shows  that  reducing  the  number  of  CD3  and  ζ–chain  ITAMs,  thereby lowering the TCR signal strength, results in autoimmunity due to a failure in deleting self‐reactive T‐cells, which are instead positively selected in the thymus (106). The authors suggest that the main reason for the TCR/CD3 complex to have a total of 10 ITAMs is rather quantitative than qualitative in order to guarantee scalable signaling and efficient negative selection. 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In vitro, binding assays have revealed the parameters for ZAP‐70 binding to the CD3 subunits (70). ZAP‐70 binding to ζ or CD3ε through its tandem SH2‐domain is highly cooperative, which ensures a high  affinity  for  the  doubly  phosphorylated ζ  or  CD3ε  ITAM. The binding  affinities  of  the  ZAP‐70 tandem  SH2‐domains  to  peptides  containing  individual  phosphorylated  ζ or  CD3ε ITAMs  was measured  and  the  hierarchy  described  as  ITAM(ζ1)  ≥  ITAM(ζ2)  >  ITAM  (CD3ε)  ≥  ITAM  (ζ3)  (71). Affinity differences of as much as 30‐fold between the individual phospho‐ITAMs suggests that ZAP‐70 may bind to ITAMs sequentially, provided that they are phosphorylated. Indeed, a study shows that ζ ITAM phosphorylation is sequential and appears to be ordered (72). The authors detected a basal level of partially phosphorylated ζ in resting T‐cells whereas fully phosphorylated ζ is induced only  upon  stimulation  with  agonist  pMHC  ligands.  On  the  other  hand,  antagonist  pMHC  ligands promote intermediate ζ phosphorylation in mature T‐cells, which did not detectably activate ZAP‐70. Along the same  lines, T‐cell clones stimulated with altered peptide  ligands (APLs)  induce only partial  ζ  ITAM  phosphorylation,  which  greatly  reduces  ZAP‐70  activation  and  PLC‐γ1  mediated phospholipid hydrolysis (74).  Fully phosphorylated ζ dimers are sufficient to promote ZAP‐70 trans‐phosphorylation and kinase activity  in  vitro, whereas monomeric ζ  fails  to  activate ZAP‐70  (65). Murine  thymocytes  exhibit  a constitutive association of ZAP‐70 with partially phosphorylated ζ, yet ZAP‐70 is not activated (66, 67). The discrepancy may originate from negative regulation loops, which do not occur in cell‐free assays. Indeed, the phosphatase SHP‐1 increases its dephosphorylation activity by directly binding to ZAP‐70, which negatively regulates ZAP‐70 kinase activity (68, 69). Substitution  of  tyrosine  319  with  phenylalanine  (Y319F)  in  the  interdomain  B  region  of  ZAP‐70 leads  to  dominant  negative  behavior  (78).  Y319F  prevents  phosphorylation  of  further  ZAP‐70 tyrosine residues such as Y493 in the activation loop. Defective kinase activity ultimately prevents antigen‐induced  IL‐2  expression.  Y319  is  a  substrate  for  the  Src  kinase  Lck;  phosphorylation  of Y319 is a critical step in activating ZAP‐70 kinase activity (79). Therefore, a ZAP‐70 mutant carrying an optimized binding site  for Lck (Y319EEI  instead of wildtype Y319SDP) displays a gain‐of‐function phenotype, encompassing increased tyrosine phosphorylation and catalytic activity. Another study suggests  that  Y315  and  Y319  function  as  an  autoinhibitory  switch,  thereby  regulating  ZAP‐70’s kinase  activity  (82).  By  phosphorylating  Y319  (and  possibly  Y315),  Lck  or  other  kinases  activate ZAP‐70, similar to the juxtamembrane region of several RTKs. These findings were supported by the crystallographic structure of ZAP‐70 where phosphorylation at Y315 and Y319 in the interdomain B stabilizes  a  conformational  change  required  to  activate  the  kinase  (83).  In  contrast  to  the  Y319F mutant,  a  Y315A/Y319A  mutant  leads  to  Y493  phosphorylation,  presumably  via  intermolecular 
trans‐phosphorylation.  The  Y315A/Y319A  mutant  protein  may  be  in  an  open  conformation  and therefore is released from autoinhibition, similar to wildtype Y319‐phosphorylated ZAP‐70 (82). 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Tyrosine phosphorylation at residue Y493 is another positive regulatory step (80, 81). Substitution of Y493 with phenylalanine (Y493F) prevents ZAP‐70 activation even if Y493F is co‐expressed with constitutively active Lck. Along the same lines, Lck is not very efficient in phosphorylating Y493 in a kinase‐inactive ZAP‐70 mutant (K369A), even when Y319 is phosphorylated and available for Lck‐binding.  This  suggests  that  Y493  in  wildtype  ZAP‐70  is  poorly  phosphorylated  by  Lck,  if  at  all. Interestingly, the K369A kinase‐inactive mutant is hyperphosphorylated at both Y319 and Y493 in Cos or 293 cells. Therefore, although not very efficient, Lck can phosphorylate Y493 under certain conditions  (79).  Hypothetically,  Lck  may  be  responsible  for  the  initial  but  rather  inefficient phosphorylation of Y493 on several ZAP‐70 molecules that trans‐autophosphorylate other ZAP‐70 molecules with which they are dimerized by paired ITAMs of the CD3 subunits. The current study shows how the level of ZAP‐70 activity controls the outcome of thymic selection. ZAP‐70 is differentially recruited and phosphorylated in the immunological synapses (IS) of DP OT‐I transgenic  thymocytes  with  antigen  presenting  cells  (APCs)  loaded  with  positive  or  negative selecting  peptides.  pMHC  ligands  with  a  TCR  affinity  just  over  the  negative  selection  threshold induce an abrupt increase in TCR and ZAP‐70 recruitment to the IS formed between a DP thymocyte and a peptide‐loaded APC. This discrete elevation of TCR and ZAP‐70 recruitment occurring at the negative  selection  threshold  is  associated  with  a  discontinuous  increase  in  ZAP‐70  enzymatic activity. This tightly regulated increase in ZAP‐70 activity accounts for the transition from positive to  negative  selection.  This  is  supported by  artificially  reducing  ZAP‐70  enzymatic  activity  using  a ZAP‐70 kinase inhibitor. Use of this inhibitor demonstrates that virtually all Y493 phosphorylation is dependent on ZAP‐70 kinase activity and results from trans‐phosphorylation. These data support the  idea that  the density of TCR/ZAP‐70  in the  IS determines the extent of Y493 phosphorylation, the amount of ZAP‐70 activity and the outcome of thymic selection. 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3.2.3 Materials and Methods  Peptides and antibodies OVA  variant  peptides were  synthesized  and  purified  as  described  (91,  92)  and  had  the  following affinity  hierarchy  for  the OT‐I  TCR: OVA >> Q4R7 > Q4H7 >> VSV  (107,  108).  Anti‐CD4  (RM4‐5), anti‐CD8β (53‐5.8), anti‐Vα2 (B20.1), anti Vβ5 (MR9‐4) and capturing anti‐ZAP‐70 (cl. 29) are from BD Biosciences. Probing antibodies anti‐ZAP‐70 (99F2), anti‐p‐Y319 (65E4), anti‐p‐Y493 (2704) are from Cell Signaling. For flow cytometry, fluorochrome‐conjugated anti‐ZAP‐70 (1E7.2) is from Santa Cruz Biotechnology. Anti‐phospotyrosine (4G10) and anti‐LAT (rabbit polyclonal) are from Upstate. Capturing  and  probing  anti‐CD3ε  (145‐2C11)  and  anti‐ζ  (H146‐968)  respectively,  were  from purified hybridoma supernatants.  Microscopy CD19+  positive  B‐cells  from  C57  Bl/6  mice  were  used  as  APCs  for  microscopy.  Spleen  cell suspensions were subjected to red blood cell lysis and depletion of CD4+, CD8α+ and NK1.1+ positive cells by monoclonal antibodies and binding to magnetic beads (AutoMACS system; Miltenyi Biotec). Non‐depleted cells (85‐90% CD19+) were stained with Cy5 mono‐reactive dye (GE Healthcare) and loaded with 2µM peptide. Thymocytes from OT‐I Rag‐/‐ β2m‐/‐ transgenic mice were stimulated with peptide‐loaded  APCs  (1:1  ratio)  by  brief  centrifugation  and  incubation  at  37°C.  Fixation  with formaldehyde,  permeabilization  with  Triton  X‐100  and  staining  with  monoclonal  antibodies  was carried  out  on  (3‐aminopropyl)triethoxysilane  (Sigma)  coated  cover  slips.  Microscopy  was performed  on  an  Olympus  IX81  fluorescence microscope.  The  recruitment  or  phosphorylation  of fluorescently  labeled proteins  in  the  synapse was  calculated as background‐corrected  ratio of  the mean fluorescence  intensity (MFI)  in the synapse divided by the MFI of a user‐defined membrane region outside  the synapse:  ‘Fold recruitment’ =  (MFISynapse – bkgd) /  ( MFIMembrane – bkgd). Values were plotted using the Prism software (GraphPad Software Inc.).  Stimulation of DP thymocytes and immunoprecipitation APCs (3LBM 13.1 B‐cell hybridomas) expressing H‐2Kb were loaded with 2µM peptide, followed by fixation  with  0.1%  glutaraldehyde.  DP  thymocytes  from  OT‐I  Rag‐/‐  β2m‐/‐  transgenic  mice  were stimulated  with  peptide‐loaded  APCs  by  brief  centrifugation  and  incubation  at  37°C.  For immunoprecipitations, cells were lysed with 1% nonionic detergent (Brij58 for TCR‐IPs, NP‐40 for LAT‐IPs  and  digitonin  for  ZAP‐70  IPs)  and  isotonic  lysis  buffer  to  generate  post‐nuclear  lysates. Immunoprecipitations were performed with 1µg of monoclonal antibody and protein G sepharose (GE  Healthcare).    SDS‐PAGE  under  reducing  conditions  and  Western  blotting  was  performed according to standard techniques. Nitrocellulose membranes were probed with primary antibodies 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and  subsequently  with  horseradish  peroxidase  (HRP)‐conjugated  secondary  antibodies.  HRP‐mediated  conversion  of  the  ECL‐reagent  (GE  Healthcare)  was  detected  on  ECL  hyperfilms  (GE Healthcare). Films were developed on a Curix80 processor  (Agfa) and analysed using  the Gel Doc 2000 densitometer and the Quantity One software (BioRad). If required, membranes were stripped with Restore Western blot stripping buffer (Thermo Scientific) and reprobed.   
In vitro kinase assay ZAP‐70 was co‐immunoprecipitated from activated TCR complexes using the monoclonal anti‐CD3ε (145‐2C11) antibody. Immunoprecipitated complexes were incubated with 0.5µg recombinant LAT (Upstate), 5mM MgCl2 and 10µM ATP for 10min at 37°C. Reducing SDS‐PAGE, Western blotting and membrane probing was performed as described above.  Fetal thymic organ culture (FTOC) FTOC was performed as described (109). In brief, thymic lobes were excised from OT‐I Rag‐/‐ β2m‐/‐ transgenic  mice  at  a  gestational  age  of  day  15.5.  Exogenous  β2m  (5µg/ml),  peptide  (2µM  for negative‐selecting and 20µM for positive selecting peptides) and varying concentrations of the ZAP‐70 kinase inhibitor were added to the FTOCs. After 7 days of culture, thymocytes were analyzed by flow cytometry. 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3.2.4 Results  
ZAP­70 recruitment and phosphorylation with positive and negative selecting ligands We  used  a  well‐defined  set  of  peptides,  inducing  positive  or  negative  selection  of  thymocytes expressing the OT‐I TCR (107, 108). Transgenic mice of the OT‐I Rag‐/‐ β2m‐/‐ mice are blocked in T‐cell  development  and  accumulate  large numbers  of  pre‐selection CD8+ CD4+ double‐positive  (DP) thymocytes.  These  DP  OT‐I  thymocytes  were  stimulated  with  peptide‐loaded  APCs  and subsequently analyzed by fluorescence microscopy. OVA, Q4R7, Q4H7 or the null ligand, VSV were used in these experiments. OVA is a high affinity negative selector for the OT‐I receptor. Q4R7 is the lowest affinity negative selector, whereas Q4H7 has the highest affinity, which still induces positive selection  of  OT‐I  thymocytes;  both  Kb/Q4R7  and  Kb/Q4H7  have  similar  affinities  for  the  OT‐I receptor  (108).  Specific  staining  for  phosphorylated  tyrosine  at  position  319  of  ZAP‐70  (p‐Y319) revealed a synapse‐specific increase in response to the negative‐selecting peptide Q4R7 compared to  the  positive‐selecting  peptide  Q4H7  (Fig1A; middle  panels).  Similar  results  were  obtained  for phosphorylation of  the  tyrosine at position 493  (p‐Y493)  located  in  the kinase domain of ZAP‐70 (Fig1A;  right  panels).  Increased  ZAP‐70  tyrosine  phosphorylation was  accompanied  by  increased ZAP‐70  and  ζ  recruitment  to  the  synapse  (Fig1A;  left  panels).  In  time  course  experiments, microscopy  images  were  analyzed  for  the  recruitment  of  ZAP‐70  and  its  phosphorylation  in  the synapse and were quantified at indicated time points (Fig1B). OVA and Q4R7, the strongest and the weakest  negative  selecting  peptides  induced  increased  phosphorylation  of  Y319  and  Y493  in  the synapse,  as  well  as  increased  ZAP‐70  recruitment.  However,  the  peak  of  Q4R7‐induced  ZAP‐70 phosphorylation and recruitment appeared to be only slightly reduced or delayed compared to OVA. In contrast, Q4H7,  the positive selector,  recruited markedly  less ZAP‐70 to  the synapse  in spite of the fact that Q4H7/Kb only has a marginally lower affinity for the OT‐I TCR compared to Q4R7/Kb. Non‐cognate VSV,  a  non‐selecting peptide  for  the OT‐I TCR  fails  to  induce ZAP‐70  recruitment  or phosphorylation. We  also  investigated  ZAP‐70  phosphorylation  and  recruitment  to  activated  TCR  complexes  by Western  analysis  in  order  to  confirm  the  results  obtained  by  microscopy  (Fig  1). Immunoprecipitated TCR  complexes  from OT‐I  Rag‐/‐ β2m‐/‐  thymocytes  stimulated with  peptide‐loaded  APCs  were  probed  for  the  presence  of  and  tyrosine  phosphorylation  of  ZAP‐70  (Fig2A). Similar  to what we observed by microscopy, ZAP‐70 recruitment  to  the TCR was enhanced under negative‐selecting  conditions.  TCR  associated  ZAP‐70  demonstrates  strong  and  transient phosphorylation  at  Y319  and  Y493.  The  positive‐selector  Q4H7  induces  a  2‐fold  reduced  ZAP‐70 association  to  the  TCR/CD3  complex  and  approximately  2‐fold  reduced  Y319  and  Y493 phosphorylation.  Stimulation  with  non‐cognate  VSV  shows  a  background  level  of  ZAP‐70 association  to  the  TCR  complex  but  fails  to  induce  any  Y319  or  Y493  phosphorylation.  This  is  in 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accordance with previous observations  that ZAP‐70  is  to  some degree associated with  the TCR ζ‐chain,  even  in  resting cells  (63). The amount of TCR captured  in  these  immunoprecipitations was similar  as  shown  by  probing  for  ζ.  Densitometric  analysis  confirmed  the  patterns  of  ZAP‐70 association to the TCR observed by microscopy (Fig2B). pMHC ligands above the negative selection threshold  induce  a  discrete  increase  of  TCR  and  ZAP‐70  recruitment  as  well  as  ZAP‐70 phosphorylation in the synapse.   
ZAP­70 kinase activity in positive and negative selection We developed an  in vitro kinase assay to assess ZAP‐70 kinase activity under positive or negative selecting conditions. Following stimulation of OT‐I Rag‐/‐ β2m‐/‐ DP thymocytes with peptide‐loaded APCs,  TCR/CD3/ZAP‐70  complexes were  co‐immunoprecipitated  at  various  times.  ZAP‐70  kinase activity was measured  using  a  recombinant  LAT  substrate  in  presence  of  ATP  (Fig3).  LAT  is  the main ZAP‐70 substrate, which orchestrates TCR downstream signaling (90, 110). The specificity of the assay was confirmed by using the ZAP‐70 kinase inhibitor XXX, which abrogated ZAP‐70 kinase activity  in  this  in  vitro  assay  (Fig3A;  lanes 1&2). Control  reactions  showed  that no ZAP‐70 kinase activity was detected in unstimulated thymocytes (Fig3A; lane3). Furthermore, endogenous LAT is not  co‐immunoprecipitated  with  the  TCR  under  these  conditions  as  shown  in  the  absence  of recombinant  LAT  (Fig3A;  lane  4).  Isotype  control  antibodies  confirmed  the  specificity  of  the immunoprecipitation (Fig3A; lane 5). These controls suggest that LAT phosphorylation in this assay specifically comes from TCR‐associated, activated ZAP‐70.  OT‐I  DP  thymocytes  were  stimulated  with  peptide‐loaded  APCs  and  ZAP‐70  kinase  activity  was determined  from  co‐immunoprecipitated  TCR/CD3/ZAP‐70  complexes  using  the  in  vitro  kinase assay.  The  negative‐selecting  peptides  OVA  and Q4R7  induced  increased  ZAP‐70  activity  at  early time points compared to the positive‐selecting peptide Q4H7 (Fig3B). The decline of ZAP‐70 activity at  later  time  points  may  be  due  to  reduced  ZAP‐70  association  with  the  TCR  complex.  ZAP‐70 dissociation  from  activated  TCR/CD3  complexes  has  been  previously  described  (111).  The  non‐cognate  peptide,  VSV  failed  to  induce  any  detectable  ZAP‐70  activity  associated  with  the  TCR (Fig3B).  Phospho‐LAT  signals were  quantified  by  densitometry  to  analyze  the  kinetics  of  ZAP‐70 activity (Fig3C). To estimate the total ZAP‐70 activity over the whole time‐course of the experiment or  particularly  the  initiation  phase  of  TCR  signaling,  we  integrated  the  area  under  the  curves (Fig3D).  In  both  cases,  the  integrated  ZAP‐70  activity  was  at  least  2‐fold  higher  for  the  weakest positive selector Q4R7 compared to the strongest positive selector Q4H7. During the initial phase of stimulation (10min),  the strongest negative selector, OVA  induced somewhat more ZAP‐70 kinase activity  than  the weak negative  selector, Q4R7  (Fig 3D,  left panel);  however,  over  the  entire  time course  of  the  experiment  (60 min)  both  negative  selecting  peptides  induced  a  similar  amount  of ZAP‐70  activity  (Fig  3D,  right  panel).  Therefore,  at  the  selection  threshold,  negative‐selecting 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ligands abruptly induce a 2‐ to 3‐fold increase in ZAP‐70 recruitment and phosphorylation, which is reflected by the integrated ZAP‐70 activity during the initiation phase of TCR signaling.  These  results  raised  the  question  whether  the  amount  of  ZAP‐70  activity  is  a  dose‐dependent determinant of thymocyte selection outcome. We wondered whether the lowered ZAP‐70 activity in presence of  the  inhibitor  could actually  convert negative  selection of DP  thymocytes  into positive selection. To assess this question we analyzed selection of OT‐I DP thymocytes in fetal thymic organ cultures (FTOC) under negative or positive selecting conditions in either presence or absence of the ZAP‐70 inhibitor.   
Partial ZAP­70 inhibition converts negative into positive selection The ability of  the ZAP‐70 kinase  inhibitor  to  influence  thymic selection outcome was  tested using FTOC  (109).  OVA  induced  negative  selection  by  deleting  virtually  all  DP  thymocytes  (Fig4A;  left panel).  In  contrast,  non‐cognate  VSV  induced  neither  positive  nor  negative  selection  (not  shown; (107)).  In  presence  of  increasing  concentrations  of  the  ZAP‐70  kinase  inhibitor  (XXX),  OVA stimulated  FTOCs  generated  increased  numbers  of  positively  selected  CD8+  SP  cells  (Fig4A;  right panels). This demonstrates that positive selection depends on low ZAP‐70 kinase activity in a dose‐dependent  way.  A  similar  phenomenon  was  observed  in  Fig4B.  In  FTOCs  stimulated  with  the weakest  negative  selector  Q4R7,  partial  inhibition  of  ZAP‐70  kinase  activity  leads  to  positive selection  of  OT‐I  DP  thymocytes  (Fig4B,  lower  panels).  Interestingly,  partial  inhibition  of  ZAP‐70 activity  produced  only  a  mild  reduction  of  positive  selection  induced  by  Q4H7  (Fig4B,  upper panels).  
Control of Y493 phosphorylation and ZAP­70 activity The  phosphorylation  of  Y493  enhances  ZAP‐70  activity,  but  it  has  been  controversial whether  p‐Y493  is  generated  by  a  separate  kinase  or  by  trans‐phosphorylation  involving  two  ZAP‐70 molecules. We addressed  this using  the ZAP‐70 kinase  inhibitor  (XXX). Compound XXX prevented pervanadate‐induced  phosphorylation  of  endogenous  LAT  in  DP  thymocytes  (Fig5A;  lanes  3&4). Untreated  samples or  the  inhibitor alone did not have any effect on LAT phosphorylation  (Fig5A; lanes 1&2). The inhibitor had no effect on ζ phosphorylation (data not shown).  Using OVA‐loaded APCs, we found that increasing concentrations of the ZAP‐70 inhibitor abrogated endogenous LAT phosphorylation with an  IC50 = 1.63 ± 0.44 e‐6 M (Fig5B). We also calculated  the IC50 of  the same inhibitor to prevent Y493 phosphorylation (IC50 = 1.76 ± 0.64 e‐6 M) (Fig5C). The two IC50 values are almost identical (p = 0.78) indicating that phosphorylation of Y493 is dependent on ZAP‐70 kinase activity. The data are also consistent with the idea that enhanced ZAP‐70 kinase activity in DP thymocytes is dependent on Y493 phosphorylation (81). However, even at the highest concentrations  of  the  ZAP‐70  kinase  inhibitor  there  is  a  residual  background  of  Y493 phosphorylation.  It has been suggested  that other kinases  initiate Y493 phosphorylation on a  few 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molecules  and  that  ZAP‐70  trans‐phosphorylation propagates  and  sustains Y493 phosphorylation (79).  As  a  specificity  control we  tested whether  compound XXX  could  inhibit  Y319 phosphorylation  or ZAP‐70  recruitment  to  the  TCR  (Fig5D  and  5E).  Even  in  the  presence  of  high  inhibitor concentrations,  ZAP‐70  was  recruited  to  the  TCR  and  its  regulatory  Y319  was  phosphorylated. These results suggest that ZAP‐70 association to activated TCR complexes and its phosphorylation at Y319 does not require ZAP‐70 kinase activity. Moreover these data confirm previous results that Y319 phosphorylation is not mediated by ZAP‐70 trans‐phosphorylation but by another kinase(s), most likely Lck (79).  To investigate the inhibition of Y493 phosphorylation in the synapse, we analyzed Q4R7‐stimulated DP  thymocytes  by  microscopy  (Fig5F).  As  described  in  figure  1,  Q4R7  induces  strong  ZAP‐70 recruitment  and Y319/Y493 phosphorylation.  In  the presence of  1 µM ZAP‐70 kinase  inhibitor,  a concentration slightly less than the IC50 of ZAP‐70 kinase inhibition (IC50 = 1.63 ± 0.44 e‐6 M), Y493 phosphorylation was markedly reduced. 38.3 ± 8.8 % of all cells stimulated by Q4R7‐loaded APCs showed  a  ≥  2‐fold  reduction  of  Y493  phosphorylation  (3  independent  experiments;  n  =  47  cell conjugates  analyzed).  In  contrast,  ZAP‐70  recruitment  to  the  synapse  and  its  phosphorylation  at Y319 remained intact in virtually all thymocyte‐APC conjugates examined. These results confirm the co‐immunoprecipitation experiments in figures 5B‐E.   
TCR/ZAP­70 ratio in positive and negative selection Following  TCR  engagement,  CD3ε  and  ζ  contain  various  phospho‐ITAMs  that  promote  SH2‐mediated ZAP‐70 binding with different  affinities  (71). We wondered whether  this multiplicity of potential ZAP‐70 binding sites is reflected in the ratio of ZAP‐70 molecules per TCR complex under different selection conditions. Using microscopy, we examined the recruitment of the TCR and ZAP‐70 into the synapse in response to positive and negative selecting ligands (Fig6A). Surprisingly, the relative  recruitment  of  TCR  and  ZAP‐70  into  the  synapse was  similar with  both  kinds  of  ligands. This was further confirmed by the integrated (total) recruitment of TCR and ZAP‐70 over the whole time‐course of the experiment (Fig6B). This result points towards a selection mechanism where the increased  number  of  ZAP‐70  molecules  in  the  synapse  is  the  consequence  of  increased  TCR recruitment.  However,  since  microscopy  cannot  distinguish  between  a  scenario  where  TCR  and ZAP‐70  are  simply  co‐localized  in  the  synapse  or  whether  there  is  a  (SH2‐mediated)  molecular association, we assessed the ratio between the two molecules by co‐immunoprecipitation.  Immunoprecipitation  of  all  TCR  complexes  from  OT‐I  DP  thymocytes  stimulated  with  peptide‐loaded APCs revealed that the relative amount of TCR associated ZAP‐70 correlated with the thymic selection potential of the presented peptide; the strong and weak negative selectors OVA and Q4R7, respectively,  induced  higher  levels  of  TCR‐associated  ZAP‐70  than  the  positive  selector  Q4H7 (Fig6C;  left panel). This  raised  the question whether  the  increased ZAP‐70 association  to  the TCR 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under negative selection conditions is due to an increased ZAP‐70 / TCR ratio or due to increased levels  of  activated  TCRs  that  are  each  associated  with  the  same  number  of  ZAP‐70  molecules. Therefore,  we  immunoprecipitated  ZAP‐70  from  stimulated  OT‐I  thymocytes  and  probed  for  the TCR/CD3 component, ζ. The level of TCR associated to ZAP‐70 was clearly higher in response to the negative‐selecting  ligands  OVA  and  Q4R7  compared  to  the  positive  selector  Q4H7  (Fig6C;  right panel).    These  data  argue  against  the  idea  that  negative  selecting  ligands  increase  the  number  of ZAP‐70 molecules  to  each  triggered TCR;  instead  these data  support  the hypothesis  that negative selecting  ligands  actually  increase  the  number  of  actively  signaling  TCRs. We  also  calculated  the relative ZAP‐70 / TCR ratio in the synapse from the values obtained in figure 6A. Indeed, the ratio remained  constant  for  all  peptides  at  all  time  points,  independent  of  their  selection  properties (Fig6D). Taken  together,  these  experiments  suggest,  that  in  the  synapses  of  DP  thymocytes  with  APCs, elevated ZAP‐70  levels  induced by negative  selection are not due  to an  increased  relative ZAP‐70 recruitment per triggered TCR, but rather to an increase in the number of TCRs that recruit ZAP‐70. For both positive  and negative selecting ligands, the relative ZAP‐70 / TCR ratio remains constant. 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3.2.5 Discussion  ZAP‐70  is differentially recruited  to synapses  in DP  thymocytes presented with  ligands of varying selection  capability.  By  fluorescence  microscopy  we  observed  a  strong  and  transient  ZAP‐70 recruitment  to  the  synapse  in OT‐I DP  thymocytes  responding  to  negative‐selecting  peptides.  (7) (Fig.  1).  In  contrast,  ZAP‐70  recruitment  was  substantially  weaker  and  delayed  in  response  to  a positive‐selecting  ligand with  an  affinity  only  slightly  below  the  selection  threshold. Activation  of ZAP‐70  in  the  synapse  was  characterized  by  phosphorylation  of  the  regulatory  tyrosine  residue Y319  in  the  interdomain  B  (78,  79)  and  the  tyrosine  residue  Y493  in  the  activation  loop  of  the kinase  domain  (81,  83).  Phosphorylation  at  both  residues was  quickly  induced  upon  stimulation with negative‐selecting  ligands, whereas  it was  clearly  reduced  in  response  to a positive‐selector. No phosphorylation was detected when DP thymocytes were stimulated with a non‐cognate ligand for  the  OT‐I  receptor.  These  microscopy  results  were  confirmed  by  co‐immunoprecipitation experiments, examining ZAP‐70’s association to the CD3 complex and its phosphorylation state (Fig. 2). Moreover,  this Western analysis  revealed a  low amount of TCR‐associated ZAP‐70 even under non‐stimulatory  conditions,  similar  to  resting DP  cells  (data  not  shown).  These  results  confirm  a previous  study  describing  a  constitutive  association  between  ZAP‐70  and  phosphorylated  ζ  in absence of TCR ligation (66). The  peptide  ligands  Q4R7  and  Q4H7  used  in  this  study  represent  the  weakest  negative  and  the strongest positive selector in the OT‐I system, with similar binding affinities as measured by pMHC tetramers  (108).  However,  the  increased  recruitment  and  phosphorylation  of  ZAP‐70  by  ligands above  the  selection  threshold  suggests  that  efficient  ZAP‐70  phosphorylation  is  a  hallmark  of negative  selection  whereas  weak  and  delayed  ZAP‐70  phosphorylation  characterizes  positive selection. ZAP‐70 kinase  activity was determined using  in  an  in  vitro  kinase  assay  and  compared  to  results obtained by microscopy and Western blot. Phosphorylation of a recombinant substrate (LAT) could be specifically attributed to ZAP‐70 enzymatic activity in the assay since a specific ZAP‐70 inhibitor abrogated phosphorylation of exogenously added LAT. In response to the negative selecting ligands OVA  and  Q4R7,  ZAP‐70  kinase  activity  was  again  quickly  induced  and  diminished  over  the  time course of the experiment (Fig. 3). The positive selector Q4H7 induced a ZAP‐70 kinase activity that was only slightly above that observed  in presence of  the non‐cognate  ligand, VSV.  Integrated over the  initial  phase  (10min) or  the whole  time‐course of  the  experiment  (60min),  negative  selectors (compared  to  positive  selectors)  increased  ZAP‐70  kinase  by  2.4‐  and  2.6‐fold,  respectively. However,  despite  the  fact  that OVA displays  a  >  10‐fold higher  affinity  for  the OT‐I TCR  than  the weak  negative  selector  Q4R7,  ZAP‐70  kinase  activity  was  not  increased  in  proportion  to  ligand affinity. Taken  together,  these  results argue  that positive  selectors, over a wide  range of  affinities 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that  are  below  the  selection  threshold  induce  a  similar  level  of  ZAP‐70  kinase  activity.    PMHC ligands with affinities  just above  the  selection  threshold  induce a discretely elevated  (2‐3  fold) of ZAP‐70 kinase activity, which is a hallmark of negative selection signaling.   ZAP‐70  mediated  phosphorylation  of  endogenous  LAT  was  investigated  using  a  specific  kinase inhibitor (compound XXX). Our experiments confirm that LAT is primarily phosphorylated by ZAP‐70  and  not  by  other  PTKs  (90),  since  endogenous  LAT  phosphorylation  was  almost  entirely prevented at high inhibitor concentrations. Additionally, compound XXX substantially inhibits Y493 phosphorylation, implying that phosphorylation of this tyrosine residue is mediated by ZAP‐70 itself (i.e. by trans‐phosphorylation). The IC50 values for the inhibition of LAT phosphorylation and ZAP‐70 Y493 phosphorylation  area  similar  (p  =  0.78),  indicating  that  ZAP‐70  kinase  activity mediates both reactions. The importance of tyrosine 493 phosphorylation to induce ZAP‐70 kinase activation has been demonstrated previously by point mutations in this residue that abrogate ZAP‐70 kinase activity (80, 81). Although these results clearly depend on the specificity of the inhibitor, ZAP‐70 is the only known Syk kinase in DP thymocytes. In  contrast,  phosphorylation  at  Y319  in  the  regulatory  domain  of  ZAP‐70  was  not  affected  by inhibiting ZAP‐70 kinase activity, which argues that this residue is a phosphorylation target of other PTKs,  such  as  Lck.  Indeed,  overexpression  studies have  shown  that phosphorylation  at Y319 was only achieved upon cotransfection with Lck (82) and Y319 was also identified as binding site for Lck (79). Microscopy studies revealed that inhibition of Y493 phosphorylation was specifically mediated in  the  synapse.  Similar  to  the  biochemical  data,  the  ZAP‐70  inhibitor  affected  neither  ZAP‐70 recruitment to the synapse nor ZAP‐70 phosphorylation at Y319.  In ZAP‐70 knockout mice, thymocytes are arrested in their development at the DP stage and fail to become positively selected (64). Negative selection was also impaired since peptide antigens fail to delete  these  cells.  Given  that  ZAP‐70  is  a  likely  branch  point  for  thymic  selection  signaling,  we wondered whether we could influence the selection outcome by modulating ZAP‐70 kinase activity. In  FTOC,  partial  inhibition  of  ZAP‐70  kinase  activity  converted  negative  selection  into  positive selection.  This  supports  the  idea  that  negative  selection  signaling  requires  a ~  2‐fold  increase  in ZAP‐70 activity in the immunological synapse.  The increase in ZAP‐70 kinase activity in negative selection might be related to a different molecular ratio of ZAP‐70 / TCR in the synapse. Previous studies have identified partially phosphorylated ζ–chains in response to antagonist ligands (72), which may provide a mechanism to alter the number of  associated ZAP‐70 molecules per TCR complex. ZAP‐70 binds  to doubly phosphorylated  ITAMs using both of its SH2‐domains (70) and has varying binding affinities for the individual ζ and CD3ε ITAMs (71). It’s conceivable that this contributes to an elevated ZAP‐70 / TCR ratio during negative selection.  However,  microscopy  experiments  indicate  that  TCR  and  ZAP‐70  are  proportionally recruited into the immunological synapse by both positive and negative selecting ligands. Negative selection  does  not  increase  the  relative  ratio  of  ZAP‐70  /  TCR  (Fig.  6).  This  finding  was  further 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supported  by  co‐immunoprecipitations  of  the  TCR  complex  and  ZAP‐70  from  APC‐stimulated  DP thymocytes.  As  expected,  TCR‐associated  ZAP‐70  was  increased  in  response  to  the  negative‐selecting ligands. However, a pulldown of ZAP‐70 and subsequent probing for TCR revealed that an increased  amount  of  TCR  is  associated  with  ZAP‐70  in  lysates  of  DP  thymocytes  that  had  been stimulated with  negative  selecting  ligands.  Therefore, we  postulate  a model  of  negative  selection signaling where increased TCR recruitment into the synapse drives a proportional increase in ZAP‐70  recruitment.  Previous  studies  have  shown  that  in  the  synapse,  coreceptor‐associated  Lck phosphorylates ζ ITAMs based on the TCR‐coreceptor interaction (107). Negative‐selecting ligands quickly  induce  close  coreceptor  approximation  and  exhibit  strong  ζ  phosphorylation  whereas positive‐selecting  ligands  promote  looser  coreceptor  association  and  therefore  reduced  ζ phosphorylation.  We  speculate  that  coreceptor‐associated  Lck  may  strongly  phosphorylate  the regulatory Y319 of TCR‐associated ZAP‐70 under negative selection conditions. Subsequently, ZAP‐70 would be released from autoinhibition and trans‐phosphorylate other ZAP‐70 molecules at Y493 in the activation loop of the kinase domain. The higher density of ZAP‐70 molecules in the synapse facilitates this process. In contrast, with positive selecting ligands the lower ZAP‐70 recruitment and kinase  activity  in  the  synapse  is  the  consequence  of  lower  TCR  recruitment.  ,  Since  the concentration  of  ZAP‐70  molecules  in  the  synapse  is  low,  Y319  and  subsequent  Y493 phosphorylation fails to promote sufficient ZAP‐70 kinase activity in the synapse to induce negative selection  signaling.  Therefore,  our  data  indicate  that  a  2‐fold  elevation  of  ZAP‐70  kinase  activity, which occurs at the selection affinity threshold is a critical parameter of negative selection signaling. 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3.2.7 Figure Legends  
Fig1. ZAP­70 recruitment and phosphorylation at the synapse  A,  OT‐I  Rag‐/‐  β2m‐/‐  DP  thymocytes  were  stimulated  with  peptide‐loaded  APCs  for  10min.  Cells were stained with monoclonal antibodies against ζ (red), ZAP‐70 (green) or phosphorylated ZAP‐70 species  (green)  and  subjected  to  fluorescence  microscopy  analysis.  Q4H7  (positive  selector) stimulations are shown in the upper panel and Q4R7 (negative selector) stimulations in the lower panel. Enriched B‐cells from C57 Bl/6 spleens (blue) were used as APCs. B,  Time‐course  of  ZAP‐70  recruitment  and  phosphorylation  at  the  synapse.  APC‐stimulated thymocytes were imaged by fluorescence microscopy (as in A) at indicated time points. Calculated ratios  (as  described  in materials  and methods)  are plotted  as  ‚fold  recruitment’  (ZAP‐70)  or  ‚fold phosphorylation’  (p‐Y319  or  p‐Y493).  For  OVA,  Q4R7  and  Q4H7,  n≥20  cell  conjugates  were analyzed and for VSV n≥10. 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Fig2. Biochemical analysis of ZAP­70 recruitment and phosphorylation  A,  Immunoprecipitation of TCR complexes  from OT‐I Rag‐/‐ β2m‐/‐ DP  thymocytes stimulated with peptide‐loaded  APCs.  At  indicated  time  points,  TCR  complexes  were  immunoprecipitated  and subjected  to Western  blot  analysis.  Co‐immunoprecipitated  ZAP‐70 was  probed with monoclonal antibodies  against  ZAP‐70  (first  row),  p‐Y319  (second  row)  or  p‐Y493  (third  row).  Membranes were stripped and re‐probed for ζ (third row) as loading control. Representative Western blots are shown from several experiments performed for each peptide (n=3 for OVA, Q4R7 and Q4H7; n=2 for VSV). B, Graphical evaluation of ZAP‐70 recruitment and phosphorylation. Western blots as described in A were quantified by densitometry. All values were normalized to 0 min and to ζ. 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β2m‐/‐ mice at gestational day 15.5 were incubated with 0.2 µM OVA in presence or absence of 100 nM, 300nM or 1 µM ZAP‐70 kinase inhibitor. After 7 days of culture, thymocytes were stained with fluorescently  labeled  antibodies  against  TCRβ,  CD4  and  CD8β  and  subjected  to  flow  cytometry analysis.  The  percentage  of  TCRβ‐positive,  CD8αβ  SP  cells  were  determined  using  the  FlowJo software. B,  ZAP‐70 kinase  inhibition at  the negative  selection  threshold.  FTOCs were  incubated with 2 µM negative‐selecting Q4R7 or 20 µM positive selecting Q4H7 in presence or absence of 1 µM ZAP‐70 kinase inhibitor. Thymocytes were processed and analyzed as in A. 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Fig5. ZAP­70 activity correlates with Y493 phosphorylation  A,  The  ZAP‐70  kinase  inhibitor  XXX  abrogates  endogenous  LAT  phosphorylation.  LAT  was immunoprecipitated with an anti‐LAT mAb  from unstimulated or pervandate‐induced  thymocytes from C57 Bl/6 mice and analyzed by Western blot. Pervanadate‐induced ZAP‐70 activity could be inhibited  by  10  µM  XXX.  LAT  phosphorylation  was  detected  by  probing  with  an  anti‐phosphotyrosine mAb (upper panel) and verified by probing with an anti‐LAT mAb (lower panel).  B, Inhibition of endogenous LAT phosphorylation. OT‐I Rag‐/‐ β2m‐/‐ DP thymocytes were stimulated for  5min  with  OVA‐loaded  APCs  in  presence  of  titrating  ZAP‐70  inhibitor  concentrations. Immunoprecipitation and Western blot analysis was performed as  in A. Phospho‐LAT bands were quantified by densitometry, normalized to non‐inhibited phospho‐LAT and subjected to non‐linear regression analysis. The half‐maximal inhibition concentration (IC50) was calculated using the Prism software. C,  D,  E  ZAP‐70  phosphorylation  in  presence  of  increasing  inhibitor  concentrations.  Cells  were stimulated  as  in  B.  Co‐immunoprecipitation  of  TCR/CD3/ZAP‐70  complexes was  performed with anti‐CD3ε mAb. Western blots were probed with either anti‐p‐Y493 mAb (C), anti‐p‐Y319 mAb (D) or anti‐ZAP‐70 mAb (E). Determination of IC50 values from corresponding signals was performed as in B. All values were normalized to ZAP‐70 recruitment obtained from E. F,  Inhibition  of  Y493  phosphorylation  in  the  synapse.  OT‐I  Rag‐/‐  β2m‐/‐  DP  thymocytes  were stimulated for 10min with Q4R7‐loaded APCs either in presence or absence of 1 µM ZAP‐70 kinase inhibitor. Cells were stained and analyzed as in figure 1A. 38.3 ± 8.8 % of the DP thymocytes showed ≤  2‐fold  reduction  of  p‐Y493  phosphorylation  compared  to  non‐inhibited  cells  (n  =  47;  3 independent experiments). 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Fig6. Relative ZAP­70 / TCR ratio in positive and negative selection  A,  ζ  and  ZAP‐70  recruitment  to  the  synapse.  OT‐I  Rag‐/‐  β2m‐/‐  DP  thymocytes  were  stimulated, stained and analyzed by microscopy as in figure 1. B,  Integrated ζ  and ZAP‐70 recruitment  to  the  synapse. ζ  and ZAP‐70 recruitment as plotted  in A was assessed over the entire time‐course. Areas under the curves were calculated manually. C,  ZAP‐70  to  TCR  association  by  co‐immunoprecipitation.  OT‐I  Rag‐/‐ β2m‐/‐  DP  thymocytes were stimulated  for  10min with APCs  loaded with OVA, Q4R7, Q4H7  or  VSV.  Co‐immunoprecipitations performed with either CD3ε (left panel) or ZAP‐70 (right panel) were probed with anti‐ZAP‐70 mAb (upper row) or anti‐ζ mAb (lower row). Signals were quantified by densitometry, normalized to the corresponding  loading  control  and VSV.  Values  are  indicated  below  the  blots.  One  representative experiment is shown of several performed. D, Relative ZAP‐70 / ζ ratio in the synapse. Values obtained from the relative recruitment of ZAP‐70 to the synapse (A) were normalized to ζ recruitment. 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4. Discussion  
4.1 A zipper model for TCR­CD8 interactions During thymic selection, TCR affinities become restricted to a window of moderate affinities for all self‐ligands  expressed  in  the  thymus,  thus  generating  a  repertoire  with  potentially  high  TCR affinities  for  antigen  to  be  encountered  in  the  periphery.  Therefore,  the  TCR  is  required  to distinguish between different binding affinities for p‐MHC ligands using a mechanism that ensures a correct readout of the receptor affinity for self‐antigens expressed in the thymus. A known protein to  influence  TCR‐pMHC  interaction  is  the  CD4  or  CD8  co‐receptor.  Therefore,  we  examined  the interaction of CD8 with the TCR in response to peptide  ligands with defined biological properties. Negative‐selecting  peptides  induced  a  strong  and  sustained  TCR/CD8  association  in  the immunological  synapse  as  measured  by  FRET  microscopy  (37,  99).  At  the  threshold  of  thymic selection,  the  weakest  negative  selector  still  generated  relatively  strong  TCR/CD8  association, whereas  the  strongest  positive  selector  induced  substantially  weaker  and  delayed  association  of CD8  with  the  TCR.  A  non‐cognate  ligand  failed  to  induce  any  detectable  TCR/CD8  association, demonstrating  that  in  absence  of  specific  TCR  recruitment  there  is  no  detectable  steady  state interaction  between  the  two  molecules.  Remarkably,  TCR/CD8  interaction  was  proportionally translated  into ζ phosphorylation, which  is most  likely mediated via the Src kinase Lck associated with the C‐terminus of  the co‐receptor (26, 30, 112). These results  indicate  that p‐MHC ligands of different  selection potential  substantially differ  in  their ability  to  recruit CD8 and  thereby, Lck,  to the TCR complex.  A conserved stretch of 8 amino acids in the constant region of the TCR α‐chain, referred to as the α‐CPM  is  involved  in  positive  selection  and  cooperation  with  the  CD8  co‐receptor  (3,  32).  We wondered whether the defect in thymic selection displayed by α‐CPM mutant thymocytes is based on  impaired  TCR/CD8  association.  FRET  microscopy  revealed  that  TCR/CD8  interaction  in  the synapse was reduced in response to negative selecting ligands. However, positive selecting ligands completely abrogated close approximation of  the co‐receptor to the TCR complex and therefore, ζ phosphorylation.  We  suggest  that  the  α‐CPM  functions  to  recruit  the  co‐receptor  into  the  TCR complex to allow efficient signal  initiation.  Interestingly,  thymocytes from CD3δ deficient mice are also defective in positive selection (113). The CD3δε heterodimer is  located on the α‐chain side of the TCR (Figure 2), implying a role for CD3δ in ligand driven association of the TCR and co‐receptor molecules. Indeed, such a model has been suggested previously (35).  We hypothesize that the trimeric complex consisting of the TCR, the p‐MHC ligand and the CD8 co‐receptor may  function  as  a  zipper  (Figure  6).  By  binding  to  the  same  p‐MHC molecule  (19),  the apposition  of  the  TCR  and  CD8  continues  towards  the  plasma  membrane  similar  to  the 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approximation of two sides of a zipper. Complete zippering only occurs in presence of an intact α‐CPM, which mediates  tight association of  the  trans‐membrane and cytoplasmic regions of  the  two molecules.  In  absence  of  the α‐CPM,  the  ζ  and  CD3  ITAMs  are  only  inefficiently  phosphorylated since coreceptor‐associated Lck fails to fully access the TCR complex (Figure 6). Hence, the α‐CPM, together with CD3δ, mediates positive selection by ensuring close approximation of the co‐receptor and therefore, efficient signaling initiation. The α‐CPM may have an equivalent function for the CD4 co‐receptor,  because  a  class  II  MHC  restricted α‐CPM mutant  TCR  also  fails  to  generate  positive selection signals (3).   
  
Figure 6. The zipper model of TCR/CD8 approximation (adapted from (4)). In analogy to a zipper, an α-CPM 
deficient TCR (green) binds to the MHC but fails to engage with the TCR at the level of the trans-membrane and 
cytoplasmic domains (left panel). Consequently, the ITAMs of the CD3 complex are inadequately phosphorylated by 
the co-receptor associated tyrosine kinase Lck. Therefore, the α-CPM functions as tooth to ensure efficient zippering 
in the direction of the plasma membrane. Only an intact α-CPM (red) mediates tight CD8 association to the TCR 
(most likely via CD3δ) and closure of the zipper (right panel). The “fully zipped” conformation allows efficient ITAM 
phosphorylation by Lck.   High‐affinity p‐MHC  ligands exhibit a  certain  independence of  the co‐receptor. An agonist peptide (OVA) can induce negative selection in fetal thymic organ cultures in absence of the co‐receptor (in OT‐I  transgenic,  CD8‐deficient mice;  (114)).  The  binding  affinity  of  agonist  ligands  for  the TCR  is characterized by low dissociation constants (KD) (115, 116). Hence, the time that an agonist engages the TCR is long and may last for several seconds. During this time, stochastic phosphorylation of the 
ζ  and CD3  ITAMs by  ‘free’  Lck may  compensate  for  the  specific  phosphorylation mediated by  co‐
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receptor‐associated Lck. On  the other hand, antagonist  ligands exhibit higher KD’s, which narrows the time window for ITAM phosphorylation. If the co‐receptor is not present to appropriately guide Lck into the TCR/CD3 complex, ζ and CD3 ITAMs will not become phosphorylated. At the same time, ‘free’  Lck  (i.e.  not  linked  to  the  co‐receptor)  may  not  have  enough  time  to  diffuse  into  the  CD3 complex  when  stimulated  by  low‐affinity  ligands.  Such  a  mechanism  potentially  explains  why positive selection is highly dependent on the co‐receptor.  CD8 binding to class I molecules is characterized by a low affinity (KD ~100µM) (117). CD4 has an even lower affinitiy for class II (KD > 100µM) (118). Nevertheless, CD8 and CD4 have been described to  promote  cell  adhesion  (15,  119).  In  accordance  with  this,  we  observe  CD8  co‐receptor recruitment to the interface with APCs presenting a non‐cognate (null) ligand for the TCR, similar to a previous study (37). CD8 is expressed at high levels in a DP thymocyte (much higher than the TCR) and therefore, binding to class I molecules in a cooperative way may partly compensate for its low affinity.  Presumably,  TCR‐independent  recruitment  of  the  co‐receptor  to  the  synapse  is  a physiological process, mediated by high  levels of  class  I molecules expressed on  thymic epithelial cells. However,  to  efficiently  induce  signaling,  the TCR  is  required  to  tightly and  rapidly associate with  the  co‐receptor.  Another  study  suggests  that  the  kinetics  of  TCR/CD8  interaction  induces phospho‐ERK  in  the  synapse  rapidly  in  response  to  high‐affinity  ligands  whereas  low‐affinity ligands exhibit delayed ERK phosphorylation (120). Thus, CD8 ensures that the TCR can specifically distinguish  between  structurally  very  similar  peptide  ligands  through  the  kinetics  of  CD8 association to the TCR, thereby translating TCR/p‐MHC affinity into a cellular signal. One apparent discrepancy in the zipper model comes from the fact that Lck associates only with 2% of  surface  CD8  (and  with  25%  –  50%  of  surface  CD4)  (121,  122),  yet  we  postulate  rapid  and sustained TCR/CD8 association and ITAM phosphorylation in response to high‐affinity ligands (and somewhat delayed kinetics in response to low‐affinity ligands), which could turn signaling initiation into a rather inefficient process. However, since the TCR affinity for p‐MHC is generally higher (KD’s in the range nM to µM (115)) than the co‐receptor’s affinity for MHC, the co‐receptor may laterally diffuse from the trimeric complex and be replaced by another co‐receptor molecule. This sampling mechanism may allow the ligand engaged TCR to eventually engage an Lck‐associated co‐receptor, which then phosphorylates the ζ and CD3 ITAMs. The probability of such an encounter is limited by the duration of TCR/p‐MHC interaction. Thus, a more dynamic model that accounts for the fact that not all co‐receptors carry Lck may modify the zipper model.  
4.2 ZAP­70 in positive and negative selection ZAP‐70 kinase activity increases in a discrete (stepwise) manner precisely at the negative selection threshold. Our experiments  indicate  that  the elevation of ZAP‐70 activity  increases ≥ 2‐fold  in DP thymocytes  stimulated  with  negative  selecting  ligands.  When  the  recruitment  of  ZAP‐70  to  the 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synapse of APC‐stimulated DP OT‐I thymocytes was measured by microscopy, the weakest negative‐selector  exhibited  2x  higher  levels  of  ZAP‐70  in  the  synapse  compared  to  the  strongest  positive selector. Similar results were found for ZAP‐70 tyrosine phosphorylation at Y319 in the interdomain B and at Y493 in the kinase activation loop. This 2‐fold increase at the negative selection threshold is reflected in the ZAP‐70 kinase activity as demonstrated by an in vitro kinase assay.  Further  evidence  for  the  impact  of  ZAP‐70  kinase  activity  comes  from  FTOC  experiments, demonstrating  that  partial  inhibition  of  ZAP‐70  activity  converts  negative  into  partial  positive selection. These results support the idea that selection outcome is controlled by the quantity (within a  narrow  range)  of  ZAP‐70  kinase  activity  in  the  synapse.  Therefore,  we wondered whether  the increased ZAP‐70 kinase activity under negative selection conditions is reflected in a higher relative ratio of ZAP‐70 molecules per TCR in the synapse. This  idea is supported by the fact that multiple ZAP‐70 binding sites exist,  i.e.  a  total of 10 potentially phosphorylatable  ITAMs among ζ2 and  the CD3 molecules. Indeed, ZAP‐70 using its two SH2‐domains has a measurable affinity for the doubly phosphorylated ITAMs of ζ and CD3ε, although there are substantial differences in binding affinity for  the  individual  phospho‐ITAMs  (71).  Another  study  shows  that  reducing  the  total  number  of ITAMs from 10 to below 3 induces a multiorgan autoimmune disease due to a breakdown in central tolerance,  suggesting  that  the  multiplicity  of  ITAMs  propagates  a  quantitative  rather  than  a qualitative signal from the TCR across the plasma membrane (106). Since the TCR signal is read out by ZAP‐70, the lack of multiple phospho‐ITAMs and therefore, ZAP‐70 binding sites, may account for this  defect  in  thymic  selection.  Therefore,  cells  that would  have  been  negatively  selected  become positively  selected  due  to  the  fact  that  the  relative  ZAP‐70  /  TCR  ratio  cannot  change  in  these mutant mice.  However,  in  our  experiments  we  did  not  observe  a  change  in  the  ratio  of  ZAP‐70  /  TCR  in  DP thymocytes  stimulated  with  either  positive  or  negative  selecting  ligands.  All  peptides  of  varying selection potential used in these studies exhibited a constant ZAP‐70 / TCR. Rather, we found that the number of TCRs recruited to the synapse of thymocyte‐APC conjugates determined the amount of associated ZAP‐70 molecules in the synapse. Clearly, the recruitment of the TCR into the synapse reflects  the  apparent  binding  affinity  of  the  TCR‐pMHC‐CD8  interaction,  as  observed  in  our experiments and as previously described (4). We suggest that pMHC ligands with binding affinities above  the  negative  selection  threshold  induce  a  ZAP‐70  density  in  the  synapse  high  enough  to induce  trans‐phosphorylation of  tyrosine 493  in  the kinase activation  loop of ZAP‐70.  Indeed, our experiments  show  that ZAP‐70  itself  is  responsible  for most of  the Y493 phosphorylation,  since a specific  ZAP‐70  kinase  inhibitor  almost  completely  abrogated  Y493  phosphorylation.  This demonstrates  that  ZAP‐70  kinase  activity  depends  on  Y493  phosphorylation.  On  the  other  hand, positive selecting  ligands  induce phosphorylation at Y493 as well. Nevertheless, positive selectors are less efficient in recruiting the TCR to the synapse and therefore, co‐associated ZAP‐70 levels and kinase activity remain low. 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